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Selkäydinvamma (SYV) on toimintakykyä heikentävä tila, jolla on suuri 
sosioekonominen vaikutus sekä vammautuneeseen henkilöön että 
terveydenhuoltojärjestelmään. Koska SYVin akuuttihoito on parantunut 
huomattavasti, myös kuntoutukselle on suuri tarve potilaiden elämänlaadun 
parantamiseksi. SYVissa hermoimpulssien kulku aivoista kohde-elimiin ja 
takaisin on estynyt, mikä voi johtaa mm. raajojen paralyysiin. Tällä hetkellä 
SYViin ei ole parantavaa hoitoa. Laajassa käytössä olevat tavanomaisen 
kuntoutuksen menetelmät eivät palauta riittävästi liikuntakykyä erityisesti 
vaikean SYVin jälkeen. Synkronoitu sähkö- ja magneettistimulaatio (PAS, 
paired associative stimulation) on suhteellisen uusi kajoamaton menetelmä, 
jossa kahta kohdetta motorisessa järjestelmässä aktivoidaan samanaikaisesti. 
Yksittäinen PAS-kerta tehostaa ohimenevästi motoristen ratojen yhteyksiä. 
Useiden viikkojen aikana annettavan PASin terapeuttista potentiaalia 
neurologisten potilaiden merkityksellisen toimintakyvyn kohenemisessa ei 
tunneta.  
Tämän väitöskirjan tarkoituksena on tutkia pitkäaikaisen PASin 
vaikutuksia käden motoriikan paranemiseen kroonisilla SYV potilailla (osatyöt 
IV, V, VI).  PAS stimulaatioprotokollaa on myös parannettu SYVin jälkeisten 
keskushermoston toiminnallisia muutoksia huomioiden (osatyöt I, II, III).  
PAS koostuu transkraniaalisesta magneettistimulaatiosta (TMS) ja 
perifeerisesta sähköstimulaatiosta (PNS, peripheral nerve stimulation). 
TMS:n  ja PNS:n synnyttämät neuroniaktivaatiot on ajoitettu kohtaamaan 
selkäydintasolla, mikä johtaa liikeratojen toimintaa parantavaan LTP (long 
term potentiation) -ilmiöön ylempien ja alempien motoneuronien välisissä 
synapseissa. Optimaalinen ajoitus määritellään laskemalla TMS:n ja PNS:n 
välinen aika eli ISI (interstimulus interval). Ns ”klassinen” PAS-protokolla 
vaatii tarkan ajoituksen jotta LTP ilmiö syntyisi. Olemme muokanneet 
klassista PAS protokollaa (käyttäen TMSaa korkealla intensiteetillä ja PNSaa 
korkealla taajuudella) jotta PAS olisi tehokkaampi SYV potilailla, joilla on 
vammasta johtuvia muutoksia hermoradoissa.  
ISIn tarkka määritys ei ole aina mahdollista SYV potilailla. Osatyössä 1 
pureuduttiin tähän ongelmaan. Käytimme PAS-protokollan muunnoksia 
erilaisilla ISI –arvoilla. Kaikki testatut muunnokset olivat tehokkaita, mikä 
viittaa siihen että kehittämämme PAS protokolla on sovellettavissa 
neurologisille potilaille. 
Osatyössä II oli kaksi koeasetelmaa. Kokeessa 2.1 haettiin optimaalisia 




PNS taajuuksia (25 Hz, 50 Hz, 100 Hz). Kaikki muunnokset voimistivat 
motorisia herätepotentiaaleja (motor-evoked potential, MEP). PAS jossa oli 
käytetty 100 Hz PNS asetuksia johti voimakkaimpaan ja pitkäkestoisimpaan 
MEP-amplitudien kasvuun. Koe 2.2 tehtiin koska liikeaivokuoren kartoitus 
neurologisilla potilailla on haasteellista. Osoittautui, että PAS toimii silloinkin, 
kun aivokuorella valittu TMS-stimulaatiopiste ei ole paras mahdollinen.  
Osatyössä III oli kolme koetta. Kokeessa 3.1 haettiin protokollaa, joka olisi 
mahdollisimman miellyttävä potilaille. Testasimme PAS 0.4 Hz taajuutta, 
jonka avulla PASin kesto pystyttiin puolittamaan. Tämä lyhennetty protokolla 
oli tehottomampi alkuperäiseen PAS-protokollaamme (0.2 Hz) verrattuna. 
Kokeessa 3.2 tutkittiin korkeampien PNS taajuuksien vaikutusta PASin 
tehoon. PAS, jossa käytettiin 100 Hz PNS:aa oli edelleen luotettavin. Kokeessa 
3.3. pyrittiin tehostamaan PAS-vaikutusta lisäämällä pulssien interaktioiden 
määrää selkäydintasolla käyttämällä TMS:aa 20Hz:n taajuudella. Tämä 
protokolla pienensi MEP-amplitudeja.  
Osatyössä IV tutkittiin uuden PAS protokollan terapeuttista vaikutusta 
kahdella SYV-potilaalla. Osatyössä V tutkittiin PASin tehokkuutta ryhmässä 
potilaita, joilla on traumaattinen SYV. Neljän  viikon PAS-hoidon jälkeen 
lihasvoima lisääntyi PAS-hoidetussa kädessä manual muscle test (MMT) -
luokituksella mitattuna. Lumestimulaatio vastakkaisessa kädessä (lume-TMS 
ja aktiivinen PNS) lisäsi MMT-arvoja merkitsevästi vähemmän kuin oikea 
PAS.  
Osatyössä VI käytimme pitkäaikaista PAS-hoitoa, jonka protokolla oli 
optimoitu terveiden koehenkilöiden mittauksissa, potilaille joilla on 
sairausperäinen SYV. Potilaiden MMT-arvot ja päivittäinen toimintakyky 
kohentuivat. Parantunut toimintakyky säilyi ainakin 6 kk hoidon 
lopettamisesta.  
PAS-protokollamme oli suunniteltu tehostamaan säilyneitä yhteyksiä SYV-
potilaiden selkäytimessä. Terveillä koehenkilöillä tehdyissä kokeissa testattiin 
erilaisia parametreja PAS-hoidon tehostamiseksi. Tehokkaimmat protokollat 
otettiin kliiniseen käyttöön. Pitkäaikaisella PASilla on terapeuttinen vaikutus, 
johon liittyy myös toimintakyvyn paraneminen. Pitkäaikainen PAS oli myös 
tehokkaampi kuin pitkäaikainen periferinen sähköstimulaatio, jota käytetään 
tavallisessa kuntoutuksessa. Menetelmän sopivuus, tehokkuus ja turvallisuus 







Spinal cord injury (SCI) is a debilitating condition with a considerable 
socioeconomic impact on healthcare resources and on the injured individuals. 
Since acute management of SCI has considerably improved, rehabilitation of 
SCI is in high demand to improve patient quality-of-life. SCI is characterized 
with an interruption of neuronal relay from the brain to the efferent organs 
and back to the brain, resulting in paralysis. Currently, there is no cure for SCI. 
Widely used conventional rehabilitation programs do not enable restoration of 
motor function in a severe SCI. Paired associative stimulation (PAS) is a 
relatively new non-invasive method that applies two-site stimulation within 
the motor system. A single PAS session results in a transient increase of motor 
output in neurological patients. However, the potential of long-term PAS on 
functionally meaningful recovery in SCI patients has not been explored. 
The goal of this dissertation was to investigate the efficacy of long-term PAS 
on hand motor recovery in chronic SCI patients (studies IV, V, VI). The altered 
physiology of the motor system in SCI individuals had to be considered 
regarding the feasibility of the PAS protocol (studies I, II, III).  
PAS was implemented with transcranial magnetic stimulation (TMS) and 
peripheral nerve stimulation (PNS). TMS- and PNS-induced pulses were timed 
to coincide in the spinal cord as determined by the value of an interstimulus 
interval (ISI). This neuronal interaction supposedly resulted in long-term 
potentiation (LTP)-like plasticity in the corticomotoneuronal synapses. A 
classical PAS protocol requires accurate determination of an ISI to induce LTP-
like plasticity in the targeted synapses. In our laboratory, the PAS protocol was 
modified (a single-pulse high-intensity TMS and a high-frequency PNS train) 
to increase the feasibility of PAS in SCI individuals. 
The exact determination of ISI is not always possible in SCI patients. Study 
I mimicked this clinically possible scenario. PAS protocols with different ISIs 
that provide non-synchronized arrival of TMS- and PNS-induced pulses were 
examined. All tested PAS protocols were effective, suggesting that this PAS 
protocol is feasible for neurological patients. 
Study II consisted of two experiments. Experiment 2.1 sought to determine 
more effective PAS settings. PAS protocols with different frequencies of PNS 
train (25 Hz, 50 Hz, 100 Hz) were tested. Although all protocols increased 
motor-evoked potential (MEP) amplitudes, PAS with 100-Hz PNS exhibited 
the strongest and most sustainable MEP potentiation. Experiment 2.2 




patients. We observed demonstrated efficacy of our PAS protocol even when 
TMS was administered to a suboptimal spot in the primary motor cortex (M1). 
Study III consisted of three experiments. Experiment 3.1 sought to 
determine a more convenient PAS protocol for SCI patients. PAS with 
increased frequency of PNS-TMS pairings (0.4 Hz PAS) that allowed a half-
duration PAS session was tested. The shortened protocol was less effective 
compared to our original PAS protocol (0.2 Hz PAS). Experiment 3.2 
continued exploring the impact of PNS frequency (100 Hz, 200 Hz, 400 Hz) 
on the effectiveness of the PAS protocol. PAS with a 100-Hz PNS train 
remained the most reliable protocol. Experiment 3.3 sought to enhance PAS 
efficacy by increasing collision of neuronal events in the corticomotoneuronal 
synapses by employing 20-Hz paired-pulse TMS in PAS. This PAS protocol 
induced a significant MEP suppression. 
Study IV assessed the efficacy of the novel PAS protocol in two subjects with 
SCI. Study V explored the efficacy of PAS in a group of traumatic SCI patients. 
After a 4-week PAS, the manual muscle testing (MMT) score improved in the 
PAS-treated hand. Sham PAS stimulation of the contralateral hand (sham TMS 
and actual PNS) induced a significantly smaller MMT score increase compared 
with the hand activated by PAS. 
Study VI applied long-term PAS with the most effective settings (100-Hz 
PNS) in a group of SCI patients with different neurological origins. In addition 
to considerable improvement in MMT scores, daily functioning of the patients 
improved. The observed improvement persisted at least 6 months after the 
PAS treatment. 
Our PAS protocol was designed to potentiate spared connections in the 
spinal cord in SCI patients. Modification of our PAS protocol demonstrated 
feasibility of long-term PAS in SCI individuals. In a series of experiments on 
healthy subjects, different parameters of the PAS protocol were tested with the 
objective of increasing PAS effectiveness. The most effective PAS protocols 
were translated to clinical research. Long-term PAS demonstrated a 
therapeutic effect that was accompanied with functional improvement. Long-
term PAS outperformed long-term PNS, which is widely used in conventional 
rehabilitation in SCI. The feasibility, effectiveness, and safety of this method 
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1.1 SCI IN NUMBERS  
Spinal cord injury (SCI) is a debilitating condition with considerable 
socioeconomic impact on affected individuals and the healthcare system. 
The World Health Organization (WHO) estimates that the annual global 
incidence of SCI is 40-80 cases per million population; 250 000 - 500 000 
people suffer SCI every year with a male-to-female ratio of approximately 
2:1. Age distribution peaks are in young adulthood and in those > 60 years, 
reflecting the leading causes of SCI. Vehicular accidents are responsible for 
approximately 40% of SCI and are characteristic for young adults, whereas 
falls (approximately 32%) are the main cause of SCI in the elderly 
population. Most studies on SCI have focused on traumatic patients; the 
incidence of non-traumatic SCI is highly variable as existing studies are not 
representative and comparable due to the multi-aetiological nature of non-
traumatic SCI. For instance, WHO estimates that non-traumatic SCI 
comprises approximately 10% of all SCIs, whereas proportions ranging 
between 30% and 80% of all SCIs have also been suggested (1). The life 
expectancy of SCI individuals is reduced and is dependent on the age at 
injury. The risk of premature death of SCI patients is over 5-fold greater 
than the risk in those without SCI. Mortality is highest in the first year after 
SCI. Mortality is strongly associated with the severity and level of SCI and 
with the availability of well-timed and high-quality acute medical care. 
Secondary complications may cause life-threatening conditions after 
injury, and their occurrence depends on ongoing health maintenance. In 
most cases, SCI leads to loss of independency. A caregiver, use of assistive 
technology to perform daily activities, or both are often needed. Social 
involvement is significantly decreased due to physical limitations, the 
negative attitude of the general public towards individuals with SCI, and 
loss of self-esteem. Clinical depression is observed in 20-30% of patients. 
Only 12% of individuals with SCI are employed at 1 year after the injury 




1.2 RELEVANT FUNCTIONAL ANATOMY OF THE SPINAL 
CORD 
The spinal cord and the brain compose the central nervous system 
(CNS). The spinal cord conveys motor, somatosensory, and visceral 
information in two directions. Descending tracts carry commands from the 
brain to the efferent organs and ascending tracts provide the brain with 
sensory feedback from the periphery. The proprioceptive and tactile 
sensory feedback modulates motor processes and enables accurate and 
proper voluntary movements (3). 
The spinal cord lies in the vertebral canal formed by 32 vertebrae. It 
extends from the brainstem at the level of foramen magnum and terminates 
at the first lumbar vertebra. As the spinal cord is shorter than the vertebral 
canal, the downstream space from the first lumbar vertebra contains 
peripheral nerves from the lumbar and sacral spinal segments before they 
exit the vertebral canal (called the cauda equina). Damage to the cauda 
equina is considered as a peripheral injury although it lies in the vertebral 
canal. 
 
Figure 1 Somatotopic organization of ascending and descending pathways and nuclei of 
the ventral horn in the cross-sectional spinal cord. Figure is modified from 
Polarlys and Mikael Häggström. The original picture is licensed under the 
Creative Commons Attribution-Share Alike 3.0 
















Figure 2 Corticospinal tract. Axons of the upper motoneurons (pyramidal cells) descend 
from M1 and synapse the lower motoneurons in the spinal cord. Lower 
motoneuron axons form peripheral nerves that innervate muscles. Reprinted from 
Anatomy & Physiology, Connexions Web 
site.  http://cnx.org/content/col11496/1.6/. The original picture is licensed 





The grey matter of the spinal cord has a transversal organization and is 
divided into 30 segments. Each segment gives rise to 30 pairs of peripheral 
nerves (the right and the left) that innervate a particular part of the body. 
Tracts and nuclei of the spinal cord are organized in a somatotopic fashion 
(Figure 1). Based on this knowledge, the character and level of damage to 
the spinal cord can be defined in a neurological examination (4).  
Voluntary movement is the product of complex interactions of different 
levels of the motor system. It begins from an internal desire to move, 
possibly generated in the limbic system and in the posterior parietal cortex. 
Thereafter, planning and programming of the movement are processed in 
the premotor and supplementary motor cortices  (5). Ultimately, the motor 
output from cortex descends along the corticospinal tract to the muscles  
(Figure 2). Voluntary motor control is implemented through the 
corticospinal tract (CST), which is responsible for fine skilled movements 
in distal limb muscles. CST consists of axons of upper motor neurons in the 
primary motor (40%), premotor (40%), and somatosensory cortices (30%). 
In humans, 15-20% of these axons form synapses directly with the lower 
motor neurons (6). The remaining axons terminate on interneurons in the 
spinal cord. CST terminations extensively overlap with interneurons of 
afferent axons that provide feedback on muscle spindle tension and joint 
position critical for precise movements (3). Finally, the lower motor 
neurons in the spinal cord activate muscles to execute the movement.  
Extrapyramidal, vestibulospinal and rubrospinal tracts provide control 
of axial and proximal musculature responsible for balance and body 
posture during movements (7). 
1.3 DEFINITION AND CLASSIFICATION OF SCI 
SCI interrupts neuronal information flow from the brain to the spinal cord. SCI 
results in diminished or completely absent function of motor and sensory 
pathways. Additionally, visceral and autonomic regulation are affected. 
Neuropathic pain and spasticity are often present in SCI individuals. 
According to the National Spinal Cord Injury Statistical Center in the United 
States, most SCI cases (47%) present with incomplete tetraplegia, followed by 
incomplete and complete paraplegia (20%), and complete tetraplegia (11%) 
(8). The American Spinal Injury Association (ASIA) developed an 
internationally recognized impairment scale (ASIA impairment scale, AIS) for 
assessment and classification of SCI (9). The AIS examination is easy to 
perform during primary examination in the emergency room and in 





Table 1 Scoring of motor function in the American Spinal Injury Association Impairment Scale 
(AIS) and Manual muscle test (MMT), ROM indicates range of motion. 
Score Description 
0 Total paralysis 
1 Palpable or visible contraction 
2 Active movement, full ROM with gravity eliminated 
3 Active movement, full ROM against gravity 




Normal active movement, full ROM against gravity and full 




for only conscious and cooperative patients as it requires performing tasks on 
demand. AIS examines sensory and motor function throughout all 
dermatomes and myotomes and defines the neurological level of SCI and the 
severity of injury. 
AIS assessment is based on the evaluation of functions in myotomes and 
dermatomes. A myotome consists of a group of muscles innervated by a 
single motor nerve; similarly, a dermatome is a skin area innervated by a 
single sensory nerve. A numerical order of myotomes and dermatomes is 
identified by a numerical order of corresponding spinal segments. 
Motor function from 10 spinal segments C5 - T1 and L2 - S1 is assessed 
bilaterally in the key muscles of the myotome. The scoring of motor 
function is presented in Table 1. Motor level is defined as the most caudal 
myotome having antigravity muscle function (score 3/5) on both sides, 
assuming that upper myotomes have a normal function (5/5).  
Sensory function is assessed bilaterally from 28 dermatomes innervated 
from C2-S5 spinal segments (Table 2). Pin prick and light touch tests assess 
tactile and pain sensations that transverse along dorsal and anterolateral 
columns of the spinal cord. The sensory level of SCI is defined as a 
dermatome with the most caudal normal sensation in tests on both sides, 




Table 2 Scoring of sensory function in AIS 
Score Description 
0 Absent 
1 Altered (hypaesthesia, hyperesthesia, deviated sensation) 
2 Normal as expected from a healthy person 
NT Not testable 
 
Thereafter, the neurological level of injury is determined as the most 
rostral spinal segment with both intact sensation and antigravity muscle 
function. 
Severity of injury is classified from A to E and defines whether SCI is 
complete or incomplete (Table 3). Incomplete injury (B-D) is characterized 
by preserved partial motor or sensory function below the neurological level. 
In complete injury (A), no motor and sensory function is observed in the 
lowest sacral segments (S4/S5). Imaging studies add accuracy to the 
diagnosis and provide information on the extent of injury. The best option 
for visualization of soft-tissue damage is magnetic resonance imaging 
(MRI) with T1- or T2-weighted mode. Computer tomography (CT) is the 
best option to detect bone pathology in traumatic SCI. A final diagnosis is 
established at the chronic stage (1 year after the injury), when spontaneous 
recovery is presumed to be complete. 
1.4 PATHOGENESIS OF SCI 
The mechanisms of injury in traumatic and non-traumatic SCI are 
different. This is due to differences in time course of the injury and in 
aetiology. Traumatic SCI results from a sudden event of trauma to the 
spinal cord that triggers pathophysiological processes consisting of explicit 
stages. In contrast, non-traumatic SCI develops gradually (from days to 
years, except in spinal cord infarction) and the underlying disease specifies 
its pathophysiology. 
Four traumatic biomechanisms damage the spinal cord. In SCI, flexion, 




































Sensory function preserved below the neurological level and 
at S4/5. No motor function below the neurological level 
 
Motor function is preserved below the neurological level and 
more than half of the key muscle below the neurological level 
have grade < 3 (0, 1, 2)  
 
Motor function is preserved below the neurological level and 
more than half of key muscles have a grade ≥ 3 (3, 4, 5) 
 




be combined in a single case. The spinal cord may be stretched, 
compressed, dislocated, or crushed by fracture or by acutely ruptured 
intervertebral discs. Traumatic SCI results from primary and secondary 
injuries. The primary injury constitutes an immediate phase that lasts up 
to 2 hours after traumatic exposure. It is characterized by disruption of 
spinal cord tissue and vascular changes, including vasodilatation, 
hyperaemia, and petechial haemorrhages. Secondary injury is 
characterized by a cascade of biochemical and cellular reactions initiated 
by the primary injury. It includes an acute phase (up to 2 days), an 
intermediate phase (days to weeks), and a late phase (weeks to months).  
The acute phase is characterized by inflammation, oedema, haemorrhages, 
and changes in myelin and neurons. Recovery from the injury starts during 
the intermediate phase. This involves astroglial scarring, revascularization, 
restoration of the blood-brain barrier, and resolution of oedema. 
Formation of astroglial and mesenchymal scars is finished in the late phase 
(10). Pathophysiological scenarios of non-traumatic SCI depend on its 
aetiology. Pathophysiology of infectious myelopathies is characterized by 
prevalence of cellular toxic damage to the spinal cord. Inflammatory 
myelopathies are characterized by biochemical and immunological 
mechanisms. Vascular myelopathies are triggered with tissue ischemia.  




by compression and resemble to some extent the traumatic compressive 
SCI. However, the time course of injury is important, as compensatory 
mechanisms are activated in chronically developing non-traumatic 
myelopathies. Non-traumatic myelopathy may occur acutely (e.g., in spinal 
cord infarction) or have a chronic course (e.g., transverse myelitis in 
multiple sclerosis). Well-recognized signs of developing myelopathy and 
successful targeted treatment enable a more favourable prognosis for 
recovery after non-traumatic than traumatic SCI (11).  
1.5 CLINICAL REPRESENTATION IN SCI 
Damage to the spinal cord is characterised by the level and extent of 
injury. Damage to the white matter that constitutes the ascending and 
descending tracts generates an upper motor neuron lesion characterised by 
muscle weakness, increased muscle tone, and increased tendon reflexes. 
Damage to the grey matter that contains the cell bodies of the motor 
neurons generates a lower motor neuron lesion and is characterised by 
muscle weakness, muscle hypotonia, and reduced or absent tendon 
reflexes. Characteristics of damage to the spinal cord give rise to a range of 
neurological dysfunction patterns, which can include a single upper or 
lower motor neuron lesion (12). However, most SCIs have combined lesions 
with features of lower motoneuron lesion at the segmental level and upper 
motoneuron lesion below the neurological level of the injury (13,14). In 
neurological examination, this combined lesion is easier to detect in 
injuries to the cervical and the lumbar spinal cord innervating the upper 
and lower extremities. 
The clinical representation of SCI is defined by the location, extent, and 
pattern of damage. Cervical injury accounts for approximately 50% of 
traumatic SCIs. Classically, cervical SCI is characterized by tetraplegia with 
sensory and autonomic dysfunction. Bowel and bladder dysfunction are 
generated by the upper motor neuron lesion. A neurogenic bladder results 
in bladder hyperreflexia with detrusor-sphincter dyssynergia. A neurogenic 
bowel presents with constipation, although sphincter reflexes are spared. 
Cardiovascular dysfunction is characterized by bradycardia and orthostatic 
hypotension. A very high cervical lesion at the level of the foramen magnum 
may be accompanied with signs of lower cranial nerve damage, resulting in 
dysarthria, dysphagia, and dysphonia. Some non-traumatic causes, such as 
Arnold-Chiari malformation, syringomyelia, or multiple sclerosis may 
affect most rostral cervical spinal cord. Cervical injury at C3-C5 elicits a 




lower motoneurons innervating the diaphragm and other muscles essential 
for respiration (12). 
Thoracic injury accounts for about of 35% of traumatic SCI. Typical 
neurological consequences are paraplegia with sensory deficits. 
Involvement of the autonomic system depends on the level of the injury. 
Neurogenic bowel and bladder are caused by upper motor neuron lesions. 
The sympathetic preganglionic neurons extend through T5-L6 spinal 
segments. The severity of sympathetic dysfunction depends on the level of 
injury; it is progressively more severe in SCIs rostral to T6. Supraspinal 
parasympathetic control is not affected in SCI as it is transmitted by the 
vagus nerve, which exits the CNS at the medullary level. However, a 
tendency to hypotension is observed, since parasympathetic vessel control 
is not balanced with the sympathetic system (12). 
Lumbar SCI includes injuries to the conus medullaris and cauda equina. 
The conus medullaris encompasses 10 spinal segments (L5-S5) within two 
vertebrae (T12-L1). Separation to segmental damage is not feasible in this 
area. Lesions of the conus medullaris result in paraparesis with lower 
motoneuron-type features, sensory deficit, and atonic bladder and anal 
sphincter. The cauda equina is a bundle of nerves originating from the L2 
segment in the spinal canal below the conus medullaris. Damage to the 
cauda equina leads to similar symptoms and signs as conus medullaris 
damage (15). Most patients also have severe low back pain. Differentiation 
of conus medullaris and cauda equina lesions is difficult in clinical 
examination and neuroimaging is usually needed for diagnosis (12). 
Approximately 20% of traumatic and nontraumatic SCI exhibit patterns 
of neurological dysfunction, suggesting anterior cord, posterior cord, 
unilateral cord (Brown-Sequard), or central cord syndromes and their 
combinations. These syndromes appear as incomplete SCI with typical 
clinical presentations. The remaining 80% have signs of complete and 
incomplete SCI with random pattern of injury (16).  
Severity of SCI is characterised by the extent of injury. International 
Standards for Neurological Classification of SCI (ISNCSCI) defines 
complete SCI as the absence of sensorimotor function at the S4-5 segments. 
A complete SCI with a zone of partial preservation (ZPP) implies that some 
pathways of CST are spared below the neurological level of injury, 





2. BACKGROUND: UP-TO-DATE SCI 
REHABILITATION 
Current acute management of SCI has improved to the extent that the 
risks of mortality from secondary conditions have diminished and the life 
expectancy of individuals with SCI approaches that of the general 
population. Therefore, rehabilitation of SCI individuals is needed to 
improve their quality-of-life by enabling social life and work. The CST 
exhibits plastic changes in response to motor training or injury (17). The 
CST is a major pathway for voluntary movements and CST lesions strongly 
correlate with motor deficit; thus the CST is a principal target for motor 
rehabilitation (18). The CST is accessible to external stimulation that 
enables application of non-invasive neuromodulation techniques in 
rehabilitation. 
2.1 CONVENTIONAL REHABILITATION 
Conventional rehabilitation programs are available in most 
rehabilitation centres and outpatient clinics. These include occupational 
and physical therapies. Conventional rehabilitation aims to enhance 
remaining skills, regain lost functions, and adjust to everyday living by 
applying compensatory strategies. For tetraplegic patients, the primary 
goal is to improve hand skills (grooming, eating, dressing, basic 
manipulation of objects, transfer to wheelchair). For paraplegic patients, 
the goal is to achieve ambulation. In general, exercising as a daily routine 
is highly important for individuals with SCI for maintaining motor and 
cardiopulmonary function and preventing muscle atrophy and vein 
thrombosis (19). 
Restorative therapy in conventional rehabilitation includes exercise 
training. Physiotherapy aims to increase muscle strength and reduce 
muscle hypertonia, pain, and spasticity, which disturb training and reduce 
overall motor performance. Numerous repetitions during motor-task 
training are expected to induce plastic changes restoring motor function. 
To regain a lost function, the patient needs to perform the exercises with 
high motivation in multiple physiotherapy sessions. With the help of an 
occupational therapist, the regained function should be integrated into the 





Exercise training can include functional electrical stimulation (FES). 
FES consists of electrical stimulation (ES) of peripheral nerves, muscles, or 
both and concomitant voluntary effort to execute an artificially induced 
movement. FES aims to selectively contract the muscles participating in the 
weak movements requiring improvement. The FES effect is mediated 
through activation of motor- and sensory-muscle fibres resulting in 
generation of reflex-based coordinated muscle contractions. A special FES 
setup may also induce antidromic activation of motor pathways with 
subsequent depolarization of the motoneurons in the spinal cord. In this 
case, FES could exert a neuromodulation effect in the spinal circuits (21). 
FES increases muscle strength and may improve blood circulation, muscle 
spasticity, muscle atrophy, and range of motions (22).  
In general, conventional rehabilitation aids motor recovery after SCI, with 
better outcomes in less severe cases.  For a patient with complete SCI, 
functionally meaningful restoration of motor function is not possible. Motor 
recovery may be better when conventional rehabilitation includes FES (23). 
However, a systematic review evaluating the effectiveness of 22 common 
physiotherapies of SCI patients justified administration of only four 
interventions (fitness training, hand and wheelchair training, and FES) with 
low-power evidence (24). For functional motor recovery leading to patient 
autonomy, conventional rehabilitation should be supplemented by other 
approaches. 
2.2 NEUROMODULATION TECHNIQUES  
The International Neuromodulation Society defines therapeutic 
neuromodulation as the alteration of nerve activity through targeted delivery 
of a stimulus to specific neurological sites in the body. The effects of 
stimulation targeting M1 and the spinal cord and their combinations have 
been tested in clinical trials. 
2.2.1 Spinal cord stimulation 
Spinal-cord ES delivered as a tonic subthreshold current facilitates 
voluntary motor activity below the level of injury in complete and 
incomplete SCI (25,26). This effect could be mediated by upregulation of 
propriospinal circuits and enhanced supraspinal input leading to increased 
excitability of the motoneuronal pool (25). This neuromodulatory effect is 




increased spinal reflexes (27). The spinal cord can be stimulated 
noninvasively with transcutaneous electrodes. 
Epidural stimulation requires surgical implantation of electrodes.  
Epidural stimulation activates large-diameter sensory afferents that 
synapse onto interneurons and motoneuronal circuits (28). Epidural 
stimulation has higher spatial resolution and activates neuronal fibres 
more selectively than transcutaneous stimulation. Spinal stimulation is 
often combined with an activity-based rehabilitation program and supports 
functional recovery by inducing adaptive neuroplasticity (29). In 
restoration of motor function, research on epidural stimulation is mainly 
focused on walking rehabilitation. 
Epidural stimulation is usually applied to lumbar spinal segments. It 
targets the central pattern generator (CPG), an intrinsic spinal network 
capable of generating rhythmic stereotyped walking-like behaviour 
independently of supraspinal input when triggered by sensory input below 
the injury (30). Lumbar spinal stimulation is thus an attractive technique 
for rehabilitation of ambulation after SCI. Some studies have applied 
epidural stimulation for upper-limb rehabilitation with less promising 
results (31,32). This may be explained by the absence of a CPG-type 
intraspinal network in the cervical spinal cord. The cervical spinal cord has 
a more complex organization of neuronal circuits needed for non-
stereotyped sophisticated hand movements. Spinal stimulation research 
demonstrates the potential for functional motor recovery after SCI. 
Particularly, a regained voluntary control over lower-limb muscles in 
complete SCI during stimulation is a promising result. However, data on 
follow-up evaluation of observed effects relevant for functional recovery 
are scarce. There is currently no strong evidence on the effectiveness of the 
intervention due to small sample sizes and lack of proper controls in the 
studies (33). Additionally, the limitations of epidural stimulation include 
risk of infection, expensive equipment, and time-intensive rehabilitation. 
Nonetheless, clinical trials have demonstrated the feasibility and safety of 
spinal stimulation.  
2.2.2 Transcranial stimulation 
The role of the M1 in SCI rehabilitation has also been studied. The motor 
system immediately responds to lesions of the spinal cord by 
reorganization of M1 (17). This results in reduction of cortical 
representation areas of weak muscles and expansion of representations of 
the strong muscles. In cervical myelopathies, mild symptoms are 
associated with extension of cortical motor representations, whereas 




(34). Spared corticospinal connections of the weak muscles are the most 
probable substrate for rehabilitation. Strengthening of motor descending 
activation would reinforce plasticity within the CST and enhance 
transmission along residual pathways ultimately associated with 
augmentation of motor output (35). 
Transcranial direct current stimulation (tDCS) is used for modification 
of cortical excitability. tDCS delivers a continuous subthreshold current 
over the scalp. Anodal tDCS promotes neuroplasticity plausibly through 
depolarization of intracortical axons and pyramidal neurons, leading to 
increasing cortical excitability that alters the firing rate of neurons (36). 
Thus, tDCS therapy may contribute to neuroplasticity within the cortex and 
along corticospinal projections. A meta-analysis of randomized sham-
controlled blinded clinical trials in SCI indicated efficacy of anodal tDCS in 
functional recovery with a small effect size. However, there was no 
significant difference in muscle strength between active and sham tDCS 
(37). 
In transcranial magnetic stimulation (TMS), a rapidly changing electric 
current is delivered to a stimulation coil. This current generates a strong 
magnetic field. The magnetic field non-invasively induces an electric field 
(EF), which induces a secondary current in the brain. TMS applied over the 
M1 at the motor threshold (MT) activates pyramidal cells trans-synaptically 
via intracortical neurons (38). The TMS-induced neuronal output from M1 
is recorded as a motor-evoked potential (MEP) from the muscles 
innervated from the stimulated M1 area.  
Repetitive TMS (rTMS) represents a sequence of high- (≥ 1 Hz) or low- 
(< 1 Hz) frequency or patterned pulses and can modulate cortical 
excitability. rTMS evokes action potentials in cortical neurons and may 
enhance synaptic transmission of intracortical connections to pyramidal 
cells leading to relevant neurophysiological changes in CST (39). A 
stimulation session consisting of hundreds of TMS pulses could induce 
plastic changes within the residual CST and contribute to functional 
recovery. Despite extensive investigation of the effects of rTMS, only a few 
clinical trials have been conducted in SCI individuals. Application of multi-
session rTMS can induce some functional improvement in SCI individuals 
(35). Overall, the available data are inconsistent and likely depend on the 
parameters of the rTMS protocol and severity and level of SCI (35). Thus, it 




2.3 INDUCING NEUROREGENERATION IN SCI 
Information on the cellular and molecular mechanisms underlying SCI 
has accumulated during the last three decades. Promising preclinical 
animal experiments have led to initial phases of clinical studies. 
SCI results in damage to the spinal cord parenchyma with disruption of 
ascending, descending, and intraspinal connections. In subacute and 
chronic stages of SCI, restoration of lost functions is possible if remaining 
connections compensate for lost connections through axonal sprouting and 
if injured axons regenerate to form new connections. CNS neurons were 
considered unable to regenerate until Aguayo demonstrated in 1981 that 
transected CNS axons can regrow into a transplanted peripheral nerve (40). 
This discovery emphasized the importance of extrinsic factors of the 
neuronal environment on regeneration. Fibroglial scar formation within 
and around the injury epicentre and a range of inhibitory molecules 
generate an environment inhibiting axonal outgrowth. Several animal 
studies counteracting this inhibitory environment have demonstrated the 
safety and potential efficacy for axonal regeneration after SCI and have 
justified translation of the research to clinical studies (41). The drug cethrin, 
which modulates responses to proteoglycan (CSPGs), the extracellular 
molecule of the glial scar, can induce moderate neurological recovery in 
acute complete SCI patients. However, the small number of the studied 
patients did not enable conclusions of drug efficacy (42). Another phase I 
clinical trial studied the effectiveness of intrathecal anti-Nogo-A antibodies 
against a myelin-associated inhibitor in 52 acute complete SCI patients. 
Although the results demonstrated limited efficacy, mild adverse effects 
favoured its administration in acute and subacute SCIs (43). The role of 
neurotrophic factors, for example brain-derived neurotrophic factor 
(BDNF), has been extensively investigated in animal studies. BDNF has 
shown efficacy in prevention of corticospinal neuron death in a spinal-cord 
injury model (44). BDNF enhances regeneration of injured axons and 
promotes synaptic strength and collateral sprouting of spared connections.  
This would be relevant to functional spontaneous recovery in patients with 
incomplete SCI. However, to provide axonal outgrowth beyond the lesion 
site and prevent the development of spasticity, high doses, precise localized 
delivery, and transient administration of BDNF should be considered (45). 
Axonal cytoskeletal dynamics, axonal transport, and epigenetic and 
transcriptional regulation define intrinsic regenerative mechanisms. 
Although several studies have demonstrated pro-regenerative activity in 
vitro and in vivo, sufficient knowledge has not accumulated on these 




2.4 CELL THERAPY IN SCI 
Cell transplantation may benefit from approaches targeting intrinsic 
and extrinsic factors of axonal regeneration in severe SCIs with extended 
lesions. Ideally, cell therapy should provide a permissive environment for 
axonal outgrowth, enhance remyelination, and replace lost neuronal 
substrate. Mesenchymal stem cells (MSCs), isolated from the bone marrow, 
can differentiate to neurons. Therapy with MSCs has been extensively 
studied in animal models of SCI and has restored neuronal tissue integrity 
leading to functional improvement through anti-inflammatory, 
neuroprotective, and pro-regenerative activity. While several clinical trials 
have demonstrated safety of MSCs, poor neurological recovery was 
observed in chronic SCI patients. The small number of studied patients 
precludes conclusions of clinical efficacy (47-50). Schwann cells have a 
principal role in regeneration of peripheral nerves and have been 
investigated for possible CNS regeneration. To date, three clinical trials on 
Schwann-cell transplants have been completed. These trials have shown 
weak neurological recovery and no transplantation-related adverse effects 
(51-53). 
In recent few decades, advances in knowledge on the pathophysiology 
of CNS injury has led to progressive growth in neuroregenerative medicine. 
The complex nature of post-injury processes in the spinal cord established 
several directions in research to investigate different potential 
therapeutical approaches. An extensive body of preclinical data on 
pharmacological and cell therapies have demonstrated safety and potential 
neurological recovery in SCI models. However, despite several clinical 
trials, a major breakthrough in regenerative medicine has not yet appeared. 
Nevertheless, substantial knowledge has been obtained that has revealed 
novel concepts and important pathways towards a SCI cure. It is becoming 
clear that single treatments cannot fully restore function after severe SCI, 
which involves a complex interplay of intrinsic and extrinsic factors after 
injury. Rather, combinatory approaches may be able to provide meaningful 




3. PAIRED ASSOCIATIVE STIMULATION 
3.1 INTRODUCTION TO THE METHOD 
In paired associative stimulation (PAS), two stimulations are applied at 
different sites of a neuronal circuit with convergence at yet another site. 
PAS, as introduced by Stefan and Classen in 2000 (54), combined 
simultaneous TMS and peripheral nerve stimulation (PNS). Donald Hebb 
postulated in 1949 that if the presynaptic cell and its postsynaptic target 
activate synchronously and persistently then the synaptic connection 
between them becomes stronger  (55). The development of the PAS protocol 
was inspired by the model of associative long-term potentiation (LTP) in 
animal studies, which were based on Hebbian synaptic plasticity. 
In the original protocol of Stefan and Classen, TMS delivered to the 
contralateral M1 was timed to converge on pyramidal cells simultaneously 
with ascending somatosensory input induced by median nerve (MN) 
stimulation. The protocol with 90 paired stimuli led to facilitation of 
corticospinal transmission, demonstrated as an increase of MEP 
amplitudes. This variant of the PAS protocol is called cortical PAS, as it is 
designed to induce synaptic changes at the cortex. 
PAS can induce bidirectional changes in the strength of targeted 
synapses depending on time relationship of the induced neuronal activities. 
Stefan et al (2000) showed that a PAS protocol with nearly synchronous 
neuronal inputs converging at M1 yielded MEP facilitation; in contrast, a 
PAS protocol that separated the cortical neuronal activations induced MEP 
suppression. The observed effects evolved rapidly, remained persistent but 
were reversible, and had a specific topography. These properties of PAS 
effect suggested that the PAS mechanism parallels the associative long-
term plasticity. Additionally, cellular mechanisms of PAS were shown to be 
similar to those for LTP induction supported by pharmacological studies 
where PAS-induced changes revealed dependence on NMDA receptors and 
calcium-channel transport (56,57). 
The properties and potential of PAS have been studied extensively (56). 
In addition to plastic changes in M1 induced by the original PAS protocol, 
several PAS modifications have displayed after-PAS LTP/LTD-like 
plasticity in M1 when TMS to M1 was coupled with afferent visual, auditory, 
nociceptive, or proprioceptive stimuli and with stimulation of the 
cerebellum, basal ganglia nuclei, the supplementary motor area, and the 




sensory cortex and the spinal cord have also been designed (56). Thus, PAS 
allows investigation of synaptic efficacy in neuronal circuits in healthy 
individuals and in individuals with different neurological conditions 
(56,58). 
The effects of even a highly focal single stimulation are not limited to 
the site of stimulation. The induced effects spread extensively throughout 
interconnected neuronal circuits in the brain. PAS has the potential to be 
more beneficial than unpaired stimulation, since converging activations 
induced with a two-site stimulation can narrow the induced effect to 
specific networks in CNS. This precision of PAS enables investigation of 
neuronal populations of scientific interest or therapeutic effects on 
selective targets. 
3.2 CELLULAR MECHANISMS OF PAS 
PAS-induced synaptic plasticity is plausibly mediated by LTP- or long-
term depression (LTD)-like mechanisms. LTP was tested early in in vitro 
experiments on hippocampal slices, where patterned ES to presynaptic 
axons led to elevation of excitatory postsynaptic potential recorded from a 
postsynaptic cell (59). According to the “classical” LTP theory,  the effect 
starts when induced neuronal activity triggers a growth of calcium 
concentration in the postsynaptic cell. Thereafter, a calcium-dependent 
second messenger system activates protein phosphorylation and initiates 
the early stage of long-term synaptic plasticity. When such neuronal 
activation is maintained, alteration in protein gene transcription in the 
postsynaptic cell leads to growth of new spines in the synapse and brings 
about long-lasting synaptic changes. The level of intracellular calcium plays 
a crucial role in determining the polarity of long-term synaptic changes. A 
strong depolarization of the postsynaptic membrane enables a rapid and 
high elevation of intracellular calcium concentration resulting in LTP; in 
contrast, a weak depolarization mediates slow and insufficient intracellular 
calcium concentration resulting in LTD. As an endpoint of this cellular 
cascade, when LTP is induced, new glutamate AMPA receptors are inserted 
from a vesicular pool of a postsynaptic cell that increases its sensitivity to 
the neurotransmitter glutamate and makes the synaptic transmission more 
efficient. In contrast, during LTD induction, a removal of AMPA receptors 
leads to weakening of the synapse. Associative long-term plasticity occurs 
when an input to a postsynaptic cell is synchronized with postsynaptic 
depolarization, replicating a natural course of neuronal transmission. In 




with spike-timing-dependent plasticity (STDP). STDP is a biological 
process that adjusts strength in synaptic connections in the CNS (59). 
3.3 PAS FOR MOTOR REHABILITATION  
 Plasticity induces structural and functional changes within the target 
circuits and systems (60). Plasticity is the basis for learning, memory, 
acquisition of motor and cognitive skills, and adaptation to injury. Animal 
models have demonstrated the possibility for long-term synaptic plasticity 
to be induced with conditioned stimulation in experimental settings  (61). 
PAS represents a stimulation paradigm to modulate synaptic efficacy in a 
long-term manner in humans. After-injury residual connections are the 
principal target for PAS (62). A single PAS session results in a transient 
increase of MEP amplitudes (58). Importantly, this neurophysiological 
change is supported by an increase in behavioural output in healthy and 
SCI individuals and is thereby relevant for motor restoration (63,64). Most 
PAS experiments have studied the efficacy of a single PAS session. A 4-week 
PAS improved leg muscle function in some stroke patients (65). 
Physiologically relevant outcomes of long-term PAS make this approach 
attractive for motor rehabilitation in CST lesions. 
3.4  COMPONENTS OF A PAS PROTOCOL 
Understanding the mechanisms of PAS enables the development of PAS 
protocols that operate in different CNS circuits. PAS consists of TMS and 
PNS. TMS and PNS parameters such as timing, intensity, and pattern of 
stimuli are considered when designing a PAS protocol for investigation of 
properties of the nervous system and for achieving desirable therapeutic 
effects. 
3.4.1 TMS in PAS 
Depending on the type of the TMS coil and stimulation intensity, TMS 
has a spatial resolution of approximately 0.5-1 cm and a limited depth of 
stimulation up to 4 cm (66). A TMS navigation system ensures accurate 
delivery of TMS pulses to a chosen spot in M1 within one stimulation session 
and between sessions (Figure 3 and 5). TMS is painless and does not have 







Figure 3 Navigation screen in eXimia NBS software. The upper row displays sections of the 
subject’s MR image. In the lower left corner of the NBS display with the subject’s MRI, 
a red-blue arrow corresponds to the TMS coil placed over the subject’s head. The 
centre of the coil is placed over a spot in M1 for ADM. Navigation of the coil is 
performed with the TMS navigation system. In the lower right corner of the NBS 
display, the Aiming Tool guides the position of the coil exactly to the chosen spot. The 
correct coil position indicator (green dot) considers the location and rotation angle of 
the coil. 
3.4.2 PNS in PAS 
Transcutaneous peripheral electrical nerve stimulation induces a 
depolarization in the nerve underlying the stimulating electrodes. This 
neuronal activity distributes along the fibres of the nerve in opposite 
directions, orthodromically, and antidromically. At a sufficiently high 
stimulus intensity, the antidromic impulse travels along the motor fibres 
up to the spinal cord. As the antidromic impulse reaches cell bodies of the 
motor neuron pool in the anterior horn, a small portion of these alpha 
motor neurons backfires and elicits orthodromic transmission towards the 
innervated muscle fibres, which is recorded as a F-response (68, 69). The 
presence of F-response in deafferented animal and human models 
indicates that F-response requires direct activation of motor axons and 
does not involve sensory reflex arch (70). Thus, a F-response reflects a 




neuron pool, providing the parameters of our PAS protocol. The values of 
an individual F-response intensity and latency are used for setting PNS 
intensity and an ISI in a PAS protocol, respectively. 
Visible muscle contraction during a nerve-conduction study indicated 
orthodromic activation of motor fibres and is observed as a M-response in 
EMG. Importantly, the M-response is elicited with lower intensity than the 
F-response, which is evoked by an electrical stimulus at supramaximal 
intensity. 
In addition to motor fibre activation, PNS applied to the mixed nerves 
also elicits orthodromic activation along the sensory fibres. This activation 
travels up to the dorsal root ganglion. 
3.4.3 Interstimulus interval 
Unlike the original cortical PAS, a spinal PAS protocol is adjusted to 
coincide the descending and the ascending volleys at the level of the spinal 
cord within the CST (64,71,72). Such a PAS protocol supposedly facilitates 
corticospinal transmission by means of strengthening the 
corticomotoneuronal synapses. ISI defines the time relationship of delivery 
of external stimuli in the PAS protocol. Consequently, ISI defines the time 
of arrival of the induced pulses at the targeted synapse. 
PAS-induced long-term plasticity is governed by principles of STDP, 
which define the effective time windows for synaptic changes. In a cell 
model, depolarization of the presynaptic membrane within 20 ms before a 
postsynaptic activation induces LTP at the synapse. If a presynaptic 
membrane is activated within 100 ms after postsynaptic depolarization, 
LTD will be induced. When the neuronal activations at the synapse are 
separated by 120 ms or more, such interaction is not relevant for synaptic 
strength change (73). Notably, the magnitude of synaptic change is higher 
when pre- and postsynaptic activations occur closer in time (74). In 
humans, greater MEP potentiation occurred when converging PAS pulses 
were nearly synchronised. Even a small shift in time of the pulse interaction 
induced MEP depression or no effect (64,75). 
In studies employing the original PAS protocol with MN stimulation, an 
ISI of 25 ms was set based on an established standard value of the N20 
latency of MN somatosensory-evoked potential in a healthy population 
(54,76). For targeting the corticomotoneuronal synapses in spinal PAS 
protocol, ISI calculation can be performed using MEP, C-root (the 
peripheral conduction time along the motor nerve measured from the 




3.5 PAS PROTOCOL ISSUES IN SCI  
3.5.1 Determination of ISI  
SCI initiates structural and functional plasticity in the spinal cord and 
supraspinal level as a part of natural recovery. This reorganization can be 
observed in electrophysiological and imaging studies. MEPs, which index 
functional integrity of CST, are often modified in individuals with SCI. MEP 
latencies in arm and leg muscles can be delayed by 2-15 ms, most likely due 
to post-injury demyelination and loss of large diameter corticospinal axons 
(78). Thus, a PAS protocol utilizing an ISI based on an average value of 
neurophysiological measures is not appropriate for SCI individuals and an 
individual calculation of ISI is required. However, even individual 
measurements may be complicated with spasticity, which hampers 
interpretation of MEPs and F-responses. In particular, significant 
spasticity blurs the exact onset of MEP and F-responses due to spike-
contaminated baseline. This compromises application of traditional PAS in 
SCI patients. A high-frequency PNS train was applied in the present PAS 
protocol to avoid such problems. A high-frequency PNS train consisting of 
6 pulses could significantly prolong postsynaptic depolarization (by 50-100 
ms) and increase the probability of pulse coincidence when precise 
determination of ISI is impossible.  
3.5.2 Significance of PNS intensity 
PNS must be delivered at an intensity sufficient to ensure antidromic 
activation reaching spinal motoneurons. In the present PAS protocol, PNS 
intensity is therefore set at an individual F-response intensity that is a 
direct equivalent of antidromic motoneuronal depolarization needed for 
PAS actualization. If PNS intensity is insufficient to activate motoneurons, 
spinal PAS fails to induce neuroplasticity (79,80). 
3.5.3 High-intensity TMS 
Individuals with SCI undergo cortical reorganization due to plasticity 
related to sensorimotor changes. Reshaped cortical maps can be expressed 
with reduction or expansion into other cortical muscle representations (81). 
PAS targets a specific pathway corresponding to a particular muscle. An 
optimal site of the specific muscle activation, a hotspot, is usually defined 




detection of such a hotspot of the target muscle. Instead, inconsistent, low-
amplitude MEPs can be elicited from several suboptimal cortical sites. In 
the present PAS protocol, TMS is administered at maximum stimulator 
output (MSO). A high-intensity TMS activates a large area in M1 and thus 
increases the probability of involving a cortical site with the optimal 
cortical representation of the target muscle. Furthermore, high-intensity 
TMS evokes multiple descending impulses corresponding to direct (D-
waves) and indirect (I-waves) activations of the pyramidal cells (38). These 
multiple descending activations result in a greater chance for pulse 





4. AIMS OF THE DISSERTATION 
The studies of this dissertation sought to explore the therapeutic 
potential of a new approach for rehabilitation of motor function in 
individuals with SCI. For this purpose, a modified PAS protocol, which was 
expected to be more robust than classical PAS setup in the injured CST, was 
applied for SCI patients.  
 
The aims of the healthy-subject studies (studies I, II, III) were as 
follows: 
1. to identify the most effective settings of the PAS protocol for inducing 
stronger and longer-lasting potentiation of CST: 
a. experiment 2.1 and experiment 3.2 sought to define the optimal 
frequency of a PNS train in the PAS protocol 
b. experiment 3.1 searched for the optimal frequency of pairings in 
the PAS protocol  
c. experiment 3.3 tested the PAS protocol with a paired-pulse TMS  
 
2. to test our modified PAS regarding feasibility in SCI patients, 
a. study I assessed the PAS protocol in a range of ISIs, addressing 
possible inaccuracy in ISI determination in SCI individuals 
b. experiment 2.2 assessed the PAS protocol with TMS delivered to 
the suboptimal target in M1, addressing possible inaccuracy in M1 
mapping in SCI individuals  
The aims of the patient studies (studies IV, V, VI) were as follows: 
1. to investigate efficacy, sustainability of the result, and safety of long-
term PAS in chronic SCI individuals: 
a. in individuals with SCI of traumatic origin in studies IV and V 
b. in individuals with SCI of different non-traumatic origins. 
 
2. to compare the efficacy of PAS to PNS only in studies IV and V. 
 
3. to investigate efficacy of intervention at different PAS settings derived 
from healthy-subject studies: 
a. PAS with 50-Hz PNS was employed in studies IV and V 




5. MATERIALS AND METHODS 
5.1 TRANSCRANIAL MAGNETIC STIMULATION 
TMS was executed with an eXimia magnetic stimulator (Nexstim Ltd., 
Helsinki, Finland). The device houses a figure-of-8-coil with an outer loop 
diameter of 70 mm generating biphasic waveform pulses (length 230 µs). The 
figure-of-8 coil provided a high-resolution M1 mapping, which is important for 
targeting specific neuronal pathways in the PAS protocols. eXimia has a 
Navigated Brain Stimulation (NBS) system (software version 4.3) that utilizes 
the subject’s magnetic resonance images (MRI) of the brain and enables 
monitoring the coil position with respect to the brain. Individual structural T1-
weighted MRIs were obtained for each participant with a 3T Siemens Verio 
scanner (Siemens Healthcare, Germany). 
EMG was recorded with surface self-adhering electrodes attached over the 
muscles (sampling rate 3 kHz, band-pass filter 10-500 Hz). The EMG device is 
built into the Nexstim TMS and enables detection and analysis of MEPs in the 
Nexstim software. MEP size was taken as a peak-to-peak MEP amplitude.  
For M1 mapping, TMS pulses were delivered to the foot or hand areas in M1 
to find a hotspot of a target muscle. Detection of MEPs was not always feasible 
in the patients (81). These patients were asked to activate the target muscle to 
decrease the motor threshold (MT) to facilitate MEPs. Thereafter, the resting 
motor threshold (RMT) was determined for the target muscle. RMT is the 
lowest TMS intensity eliciting at least 5 MEPs with an amplitude exceeding 50 
µV out of 10 consecutive stimuli. Thereafter, MEP latency was calculated from 
an average of 10 MEPs elicited by TMS at an intensity of 120% RMT. For 
patient studies, the target muscles for M1 mapping were abductor digiti minimi 
(ADM), abductor pollicis brevis (APB), and brachioradialis (BR). For healthy 
subject studies, the abductor hallucis (AH) muscle was used. TMS was 
delivered to a hotspot of the target muscle during PAS and MEP 
measurements.  
5.2 PERIPHERAL ELECTRICAL STIMULATION AND           
F-RESPONSES 
A Dantec Keypoint electromyography device (Natus Medical Inc., 




22 X 30 mm (Neuroline 720, AMBU A/S, Ballerup, Denmark) were used for F-
response and MEP measurements and PNS. 
In studies on healthy subjects, the right tibial nerve (TN) was stimulated 
with electrodes placed under the right medial malleolus. EMG was recorded 
with electrodes placed over the right AH. 
In patient studies, the MN, ulnar (UN), and radial nerves (RN) were 
stimulated. Two electrodes were placed in the middle of the inner wrist and at 
the sulcus ulnaris antebrachia for MN and UN stimulation, respectively, and 
above the elbow for RN stimulation. Recording electrodes were placed over the 
bulks of APB, ADM, and BR muscles. During RN stimulation, stimulating 
electrodes were gently pressed against the skin to elicit F-responses; the same 
procedure was done during PAS. 
The same electrode position was used for a given muscle during recording 
of MEPs and F-responses and stimulation for PNS during PAS and PNS for F-
response measurements. 
A single 0.2-ms square-wave pulse was applied at suprathreshold intensity 
to measure F-responses. A minimum latency out of 10 F-responses was used 
for calculation of ISI. For further analysis, maximum F-response amplitude 
and persistence were also measured.  
For determination of PNS intensity in the PAS protocol, a minimum 
intensity value of F-response elicited with a single 1-ms square-wave pulse was 
recorded. The F-response intensity was measured with the same pulse 
duration as PNS given during PAS. For individuals experiencing unpleasant 
sensations during PNS, EMLA cream (lidocaine 2.5% and prilocaine 2.5%) was 
applied over the area of stimulation.  
 
5.3 SETTING A PAS PROTOCOL 
The PAS protocol was individually adjusted for each healthy subject and 
patient to increase its efficacy. ISI was calculated by the formula F-latency 
minus MEP-latency (72) (Figure 4). ISI indicated a delay between TMS and 
PNS, providing a simultaneous arrival of orthodromic and antidromic volleys 
induced by a single TMS and the first pulse of a PNS train to the spinal cord 
(except in study II, experiment 1). A positive ISI standed for PNS preceding 
TMS and a negative ISI (in a reverse order). Presentation® software 
(Neurobehavioral Systems Inc., Albany, NY, USA) delivered the trigger pulses 
for TMS and PNS over PAS according to the calculated ISI. A single TMS pulse 




at 96% of MSO for experiment 3.3. PNS during PAS was delivered as a train of 
6 pulses in all experiments. The setup of PAS is displayed in Figure 5. 
 
 
Figure 4 An example of ISI calculation for lower limb. (a) Schematic representation of the 
conduction time measurements performed before the PAS protocol. TN stimulation 
electrode placing is shown. The recording electrodes are placed over AH. uCT, upper 
motoneuron conduction time; lCT, lower motoneuron conduction time. Schematic 
representation. (b) Calculation of the individual ISI for the PAS protocol on the basis 
of measurements shown in (a). F, F-latency; M, M-latency; MEP, MEP-latency from 
cortical TMS. Modified from Shulga et al, 2015  (72). The original publication is 
distributed under Creative Commons Attribution. 
 
5.4 EXPERIMENTAL DESIGN 
For both healthy subjects and patients, the general exclusion criteria were 
contraindications to TMS. Subjects with epilepsy, metal inclusion in the head 
area, pacemaker, hearing device, and high intracranial pressure were excluded 
(82). Additionally, MRI of the brain was performed to exclude subjects with 
pathological findings. All studies were approved by the ethical committee of 
Helsinki University Hospital (HUS/1280/2016). The purpose and main 
principles of the study were described to the subjects and patients. Thereafter, 




that they could discontinue a study at any point without providing a reason. 
PAS to the one target muscle consisted of 240 TMS-PNS pairings at 0.2 Hz (20 
min) except for experiment 3.3. 
 
 
Figure 5 Setup of PAS. The subject is receiving PNS to left MN and TMS to the right hemisphere 
(cortical representation of left APB). The trigger computer launches the TMS and PNS 
accordingly to a calculated ISI. Adapted from Tolmacheva et al, 2019 (study II). The 
original publication is distributed under Creative Commons Attribution 4.0 International 
License. 
5.4.1 Healthy subject studies 
All subjects were asked to avoid caffeine intake for at least 6 hours before 
the stimulation session and to avoid intensive physical activity 1 day before the 
stimulation. At least 7 days separated the experiments to exclude extension of 
PAS effect of a previous stimulation session to a subsequent one. All 
stimulation sessions within one study were performed in a random order. The 
subjects were asked to imagine movement that would be induced during the 
stimulation (toe flexion of their right foot) to fulfil the same condition as in our 
patient study. Detailed information on experimental design of studies I, II, and 
III is presented in Table 4.  
5.4.1.1 STUDY I 
Study I addressed the role of an ISI in the PAS protocol. Five subjects 
underwent 10 stimulation sessions. One PAS session was set with ISI of 0 ms 
assuming that a TMS pulse is timed to coincide with the first pulse of the PNS 




with ISIs of -10 ms, -5 ms, +5 ms, +10 ms, and +300 ms. A positive ISI 
indicates that the first pulse of the PNS-induced volley precedes the TMS-
induced volley at the corticomotoneuronal synapses before, and a negative ISI 
indicates that PNS-induced volleys follow the TMS-induced volleys. Control 
sessions assessed the role of only TMS and PNS applied with the parameters 
used in the PAS protocol. Additionally, we conducted one PAS session with ISI 
0 ms without motor imagery and one PAS with outcome evaluation up to 60 
min (Table 4). 
5.4.1.2 STUDY II 
The aim of the experiment 2.1 was to investigate how the frequency of PNS 
trains in a PAS protocol affects PAS outcome. PAS protocols with PNS of 25 Hz 
(PAS/25) and 100 Hz (PAS/100) were compared with the previously used 50 
Hz (PAS/50). A control session of PNS only at the most beneficial frequency 
(100 Hz) derived from this experiment was conducted in 5 subjects.  
Experiment 2.2 studied the effect of precision of M1 mapping on PAS. The 
most effective PAS settings obtained from experiment 2.1 (PAS/100) were 
applied. After finding a hotspot, four adjacent suboptimal spots in M1 for the 
right abductor hallucis (AH) were selected equidistant from the hotspot (Study 
II, Figure 1, B). Thirty MEPs were elicited from these four suboptimal spots. 
The “weakest” suboptimal spot, determined as a spot with the smallest MEP 
average, was chosen as a suboptimal TMS target in PAS. PAS was administered 
for three consecutive days, as repeated PAS produces more persistent effects 
than a single-session PAS (76). The outcome was measured with 30 MEPs 
elicited from the stimulated suboptimal spot and the adjacent area, including 
the hotspot and another suboptimal spot (n=2 x 30 =60 MEPs) immediately 
after each PAS session and on the eighth day. 
5.4.1.3 STUDY III 
Experiment 3.1 was designed to investigate possibilities to shorten the PAS 
protocol without attenuation of its effect. Our previously used PAS/100 at 0.2 
Hz (TMS and PNS paired every 5 s, total 240 pairings, stimulation for 20 min) 
was compared with PAS/100 at 0.4 Hz (TMS and PNS paired every 2.5 s, total 
240 pairings, stimulation for 10 min).  
Experiment 3.2 investigated whether further increase of PNS frequency in 
the PAS protocol could strengthen PAS effect. The PAS protocol with a PNS of 
200 Hz (PAS/200) and 400 Hz (PAS/400) was compared with a previously 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































by adding a second pulse to TMS. A 20-Hz paired pulse TMS was used for 
pairing the first and the second TMS pulses with the first and the last pulses of 
a 100-Hz PNS train. The PAS protocol with 20-Hz paired-pulse TMS at the 
most effective parameters as was derived from previous experiments (0.2 PAS 
with 100-Hz PNS) was examined. 
5.4.2 Patient studies 
Long-term PAS with different settings in patients with different SCI 
aetiology and for different durations were applied in studies IV, V, and VI 
(Table 5). The studies were registered at clinicaltrials.gov (NCT03459885). 
Most patients had chronic SCI and tetraplegia. These patients received PAS for 
hand muscles innervated by MN, UN, and RN. One patient with paraplegia 
participated in study IV; she received PAS for leg muscles innervated by TN 
and by peroneal nerves (PN). Nerves supplying the weak muscles were selected 
for stimulation. During stimulation, patients were asked to imagine induced 
movement, as motor imagination facilitates corticospinal transmission 
(83,84). PAS was delivered 5 times a week during the first 2 weeks and 3 times 
a week thereafter. It was assumed that more intensive exposure in the 
beginning of the intervention is required when corticospinal connections are 
still weak. The patients maintained the same conventional rehabilitation and 
medication during PAS as before the study to ensure that the observed changes 
were due to PAS. A hand motor score was evaluated before, immediately after 
PAS, and during the follow up. Additionally, spasticity, sensory function, F-
responses, neuropathic pain, functional tests, and hand dynamometry were 
examined. Patients were not evaluated on the day when they had unusually 
elevated spasticity, pain, or both in tested extremities to avoid downgrading of 
the test. 
5.4.2.1 STUDY IV 
Study IV was an open-label proof-of-principle study of two traumatic SCI 
patients, one with paraplegia and the other with tetraplegia. The paraplegic 
patient received PAS to left PN and left TN. Each nerve was stimulated for 30 
min during the first 9 weeks; from the week 10 onwards, PAS was administered 
bilaterally until week 21 of the intervention. The tetraplegic patient received 
PAS to one hand and an additional control PNS/50 to the contralateral hand 
within one stimulation session for 12 weeks; during the next 12 weeks PAS was 
administered to the contralateral hand alone. The patients and evaluating 
physiotherapist were familiar with the stimulating protocol. Outcome was 
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1-month follow up. Motor function was assessed with MMT and MEPs. 
Additionally, EMG of some muscles innervated by the stimulated nerves was 
recorded in the paraplegic patient. Sensory score was evaluated before and 
after the stimulation; neuropathic pain was additionally evaluated at the follow 
up. 
5.4.2.2 STUDY V 
Study V explored PAS in 5 chronic traumatic SCI patients. A double-blind 
randomized sham-control study was designed. In 5 SCI patients, PAS/50 was 
administered to a randomly selected hand; the contralateral hand received 
sham TMS combined with PNS. The intervention lasted 4 weeks and included 
16 stimulation sessions. PNS was administered using the same parameters as 
in the PAS protocol. Sham TMS was delivered with a TMS coil separated with 
a 75-mm plastic block placed between the TMS coil and the patient’s head. 
TMS intensity was the same as in actual TMS in PAS. PAS and sham-PAS were 
performed in alternating order at every session. The main outcome measure 
was MMT evaluated before the start of PAS, after the intervention, and at the 
1-month follow up. Spasticity score and neuropathic pain were evaluated at the 
same time. Sensory score, F-responses, and EMG were evaluated before and 
after the intervention. 
5.4.2.3 STUDY VI 
Study 6 explored the efficacy of PAS in neurological SCI. Five chronic 
tetraplegic SCI patients with different neurological origins participated in the 
study. PAS/100 was selected for the intervention as this was the most effective 
protocol obtained in study II (85). PAS was administered to the hand with 
lower MMT score for 6 weeks in 22 stimulation sessions. The contralateral 
hand was not stimulated. Patient performance was assessed before and after 
the intervention, and at 1-month and 6-month follow ups. Motor function was 




5.5 OUTCOME MEASURES 
5.5.1 MEP 
In studies on healthy subjects, the outcome was measured with an average 
of 30 MEPs (average of 10 MEPs in study I) up to 60 min after the intervention 
to evaluate sustainability of PAS effect. MEPs were elicited with TMS delivered 
at intensity of 120% RMT and sampled at a 3.3-s interval. MEPs contaminated 
with spikes in EMG activity during a 200-ms pre-stimulus interval were 
discarded from analysis to exclude influence of muscle preactivation on MEP 
size (86). MEP changes were calculated for each post-PAS evaluation as a ratio 
of post-to-pre-MEP average (MEP change = post-PAS MEP/pre-PAS MEP * 
100%). A positive value indicated amount of MEP potentiation and a negative 
value indicated MEP depression. 
In study IV, 30 MEPs were recorded from left ADM, left BR, and left and 
right APB in a tetraplegic patient and from left TA and the left gastrocnemius 
muscle (GC) in a paraplegic patient before, during, after the intervention, and 
at the 1-month follow up. MEPs were not evaluated in studies V and VI.  
5.5.2 MMT 
Motor score was assessed with the MMT. An experienced physiotherapist 
evaluated each hand and leg muscle separately (Table 1). Only muscles with a 
motor score below 5 at evaluation before the intervention were considered for 
overall analysis. 
In study IV, the evaluating physiotherapist was familiar with the 
experimental setup but did not have access to the results of previous 
examinations. In studies V and VI, the physiotherapist did not know the 
experimental setup. An average of change in MMT was defined for each 
evaluation and MMT difference between the evaluations was calculated.  
5.5.3 Spasticity 
The same physiotherapist evaluated spasticity with the Modified Ashworth 
Scale on the same day as MMT (Table 6). The spasticity score was analysed in 
a similar way as the MMT assessment.  
In study V, spasticity was additionally assessed from EMG signals. The 
number of spasticity-related spikes in the 500-ms interval preceding a MEP 
was counted visually in offline analysis. A spike event was identified as a sharp 
















no increase in muscle tone 
 
slight increase in muscle tone of ROM 
 
more marked increase in muscle tone through most of the ROM 
 
considerable increase in muscle tone, passive movement difficult 
 
affected part(s) rigid in flexion or extension 
 
ROM, range of motion. 
 
 
(after minus before) was used for statistics. Fifteen MEPs were used for the 
analysis of APB, ADM, and BR measured before and after PAS. 
5.5.4 Sensory score 
Sensory assessment was performed by a researcher familiar with the 
experimental setups according to the ASIA exam sheet (Table 2). Light-touch 
and pin-prick scores at the C2-T10 dermatomes (from C2-S5 dermatomes for 
a paraplegic patient in study I) were assessed bilaterally before and after the 
PAS treatment. A sum of sensory score was calculated for each patient and the 
difference between evaluations was analysed. In study VI, sensory function 
was not assessed, as studies IV and V did not reveal significant changes of 
sensory scores.    
5.5.5 Neuropathic pain 
Neuropathic pain was quantified with a Visual Analog Scale (VAS). VAS is a 
subjective measure of the amount of pain. The VAS is scored from 0 to 10, 
where 0 represents no pain and 10 the worst imaginable pain. Patients 
estimated the pain in VAS scale before and after the intervention and at the 
follow up. 
5.5.6 Hand strength and dexterity  
The patient sat straight in a chair during the tests. The arm was adducted 




and arm position unchanged during the test. Each test was performed three 
times and the best score in kilograms was used for analysis. 
Evaluation of mechanical hand grip strength was performed with an 
ExtraTM Hydraulic Hand Dynamometer (North Coast Medline, Inc., USA). The 
device handle was adjusted to the patient’s hand for comfortable task 
performance. Pinch dynamometry was performed with a Baseline® 
Mechanical Pinch gauge (Fabrication Enterprises Inc., USA) for evaluation of 
key pinch, tip pinch, and palmar pinch. In addition to mechanical 
dynamometry, digital dynamometry was performed with the rehabilitation 
device PABLO (Tyromotion GmbH, Austria). The initial patient position was 
the same as for mechanical dynamometry. However, measurement of grip and 
pinch force was encouraged with assistant movements of the body during 
digital hand dynamometry. Therefore, digital dynamometry expressed 
comprehensive performance of the task, reflecting hand ability in everyday life. 
Unilateral manual dexterity was evaluated by the Box and block test (BBT). 
The BBT consists of two equal compartments divided with a separation wall 
and blocks that are collected in one compartment before task performance. 
The task is to transfer blocks from one compartment to another over the 
separation wall with one hand during a 60-s period. The result is the number 
of the transferred blocks. 
5.6 DATA ANALYSIS 
All statistical analyses were performed with SPSS 22.0-25.0 software. The 
data are presented as mean ± standard error (SE). 
Data from all patient studies were analysed with Wilcoxon signed-rank test. 
In healthy-subject studies, amplitudes and latencies from an average of 30 
MEPs of each evaluation were evaluated. Data were assessed for normality 
with the Kolmogorov-Smirnov test. The data were non-parametrically 
distributed except in experiment 2.1. Non-parametric data were analysed with 
Wilcoxon signed-rank test (study II, experiment 2.2, and study III) to compare 
the averages of MEP amplitudes pre-PAS vs post-PAS within one PAS protocol. 
To detect differences between PAS protocols, Kruskal-Wallis test (study I) and 
Friedman test (experiment 2.2, study II) were applied. In experiment 2.1, the 
data were distributed normally and ANOVA with repeated measures and 




6. RESULTS AND DISCUSSION 
6.1 STUDY I: 
A modified PAS protocol is effective in a range of ISIs 
ISI determination is crucial for PAS outcome and is often challenging in SCI 
patients as they have altered physiology in the corticospinal tract and spike-
contaminated EMG. This study tested the efficacy of the modified PAS protocol 
with different ISIs to identify the most feasible PAS settings for clinical 
application. 
6.1.1 Results 
MEPs of all subjects in all the tested PAS protocols (ISI ±10 ms; ±5 ms, 0 
ms) increased significantly immediately after the intervention with no 
difference between the protocols: 196 ± 23% at ISI -10 ms, 179 ± 17% at ISI -5 
ms, 166 ± 31% at ISI 0 ms, 196 ± 14% at ISI +5 ms, 189 ± 9% at ISI +10 ms (p 
= 0.043 for all protocols). PNS and TMS delivered separately had no effect on 
MEP amplitudes (98 ± 11%, p = 0.69 for PNS, 94 ± 10%, p = 0.89 for TMS) 
(Figure 6). For individual averages of MEPs, see study I, Table 2. 
6.1.2 Discussion 
All PAS protocols induced a robust MEP potentiation. This contrasts with 
findings from studies that employed a conventional PAS protocol in healthy 
subjects (64,75) and SCI patients (63). Taylor JL and Martin PG (2009) tested 
seven PAS protocols at different ISIs ranging from -15 ms to +20 ms in healthy 
subjects and observed an LTP-like effect in MEPs induced only by the PAS 
protocol where the estimated activations of presynaptic and postsynaptic 
membranes were nearly synchronous, whereas the other six protocols induced 
depression of MEPs or did not have any effect (64). 
Notably, PAS with ISI of 0 ms potentiated MEP less than the other four 
protocols. This may be explained by the high intraindividual variability to PAS 
depending on non-controlled subjective factors (see paragraph 7.3). It is also 
probable that a high-frequency PNS train employed in the modified PAS 
protocol enables prolonged postsynaptic depolarization and provides a larger 





Figure 6 MEP potentiation induced by PAS protocols with different ISIs measured 
immediately after PAS. A significant increase of average MEP amplitudes at all 
tested protocols was observed. Only PNS and only TMS did not induce MEP change. 
Adapted from Shulga et al, 2016 (study I). The original publication is distributed under 
the terms of the Creative Commons Attribution License. 
Accordingly, presynaptic activations for all non-synchronizing ISIs (±5, ±10 
ms) may fit into LTP and LTD time windows preceding following postsynaptic 
activation induced by a high-frequency PNS train. If both LTP and LTD 
interactions exist in the -20 to +10 ms time range, LTP overtakes LTD (73) 
(Figure 7). This suggests that the present PAS protocol regulates ISI-
dependent outcome such that PAS enhanced MEPs at a wide range of ISIs. 
All stimulation protocols were performed with motor imagery of the 
targeted movement. Since motor imagery lowers the motor threshold (87) 
frequently elevated in SCI patients, this approach probably increases the 
efficacy of TMS and PAS protocols.  One control PAS protocol with ISI of 0 ms, 
conducted without motor imagery, elicited a similar MEP potentiation as the 
other PAS protocols. It is probable that cortical activation induced by TMS at 
the highest possible intensity in our PAS protocol exceeds the effect of motor 
imagery at least in healthy subjects. Nevertheless, performing motor imagery 
during PAS in SCI patients could be useful as they often have diminished 
corticospinal transmission. Motor imagery might also involve secondary 
motor areas into synchronous activation induced by PAS. 
ES is widely used during conventional rehabilitation for neurological 
patients. Substantial evidence indicates that ES modifies MEPs. However, the 
efficacy of PNS depends strongly on chosen parameters such as frequency, 
intensity, pulse waveform, and duration of stimulation (88). The control 





Figure 7 An example of TMS-PNS pairing in our PAS protocol under non-synchronous 
conditions. A single TMS pulse does not align with any of the 6 pulses of the PNS 
train. Instead, the TMS pulse drops between two subsequent PNS pulses. When 
TMS pulse is considered to interact with the preceding PNS pulse; LTD induction is 
expected; LTP induction is expected with the following PNS pulse. When LTP and 
LTD conditions are implemented at the same time, the net effect of this neuronal 
interactions results in LTP (73). 
 
effect on MEP amplitudes. TMS alone also does not modify MEPs at the group 
level. This is consistent with observations of the effects of low-frequency (≤ 1 
Hz) rTMS that suppresses or has no effect on corticospinal excitability (89,90). 
Chen et al. applied 0.1-Hz TMS at suprathreshold intensity for 1 hour and  
showed no MEPs changes, whereas a 0.9-Hz TMS protocol suppressed MEPs 
(91). It is thus unlikely that the 0.2-Hz TMS and PNS used in our PAS protocol 
could alone contribute to MEP potentiation after PAS.  
Overall, our PAS protocol is designed to produce multiple descending and 
ascending volleys in the CST and seems to establish more complex interactions 
between volleys than the conventional PAS. It reduces influence of strict spike-
timing on PAS outcome as demonstrated by results of the study I. This feature 
renders some freedom with respect to ISI determination and thus makes PAS 




6.2 STUDY II 
6.2.1 Experiment 2.1 
Increasing frequency of PNS train potentiates PAS outcome 
This study compared the effectiveness of PAS protocols with different 
frequencies of PNS train. 
6.2.1.1 RESULTS 
All three tested PAS protocols significantly increased MEP amplitudes at all 
time points as assessed by ANOVA with repeated measures with a Greenhouse-
Geisser correction for multiple comparisons (F (1.076, 31.210) = 9.488, p = 
0.004). A significant difference was observed between PAS/100 and PAS/50 
(p = 0.009, 158 ± 25% 100 Hz vs 50 Hz at all time points) and PAS/100 and 
PAS/25 (p = 0.016, 151 ± 17% 100 Hz vs 25 Hz) and no difference between 
PAS/25 and PAS/50 protocols as measured with pairwise comparisons by 
Bonferroni post-hoc analysis. PAS/100 induced the strongest potentiation at 
all time points. In contrast, control PNS/100 did not show MEP potentiation 
at any time point (Figure 8).  
 
Figure 8 MEP potentiation induced by PAS protocols with PNS of 25 Hz, 50 Hz, and 100 Hz. 
PAS with 100-Hz PNS displayed the highest and most sustainable MEP potentiation. 
PNS only did not change MEP amplitudes. Adapted from Tolmacheva et al, 2019 
(study II). The original publication is distributed under Creative Commons Attribution 





In this study, PAS protocols with a PNS train at lower (25 Hz) and at higher 
(100 Hz) frequency than the previously used 50-Hz PNS were tested in 10 
healthy subjects. Results revealed that a PAS protocol with a 100-Hz PNS train 
induced the strongest MEP potentiation at all time-point evaluations. 
Stjöström et al (2001) implemented a multifaceted approach in biophysical 
cell models to elucidate mechanisms of STDP (73). They demonstrated that 
temporal correlation of pre- and postsynaptic activations is not the only 
determinant of the existence and polarity of STDP. STDP is also influenced by 
firing rate, excitatory postsynaptic potential (EPSP) size, amount of 
postsynaptic depolarization, and input cooperativity. A low-frequency 
induction protocol (such as our 0.2-Hz PAS protocol) does not generate LTP 
in the absence of sufficient EPSP, but LTP can be rescued with an additional 
postsynaptic depolarization. Such depolarization could be generated by a high-
frequency PNS train in our modified PAS protocol. High stimulation frequency 
may generate stronger postsynaptic depolarization. LTP magnitude correlates 
positively with the size of postsynaptic depolarization (73). Hence, a high-
frequency PNS train would yield a strong postsynaptic depolarization, 
resulting in more effective PAS. Indeed, PAS/100 induced stronger and more 
persistent MEP potentiation.  
TMS administered at 100% of MSO intensity in a PAS protocol may also 
contribute to MEP potentiation. Suprathreshold TMS activates a large area of 
the cerebral cortex. In addition to M1, somatosensory and premotor areas may 
also be activated depending on the orientation of the TMS coil. Moreover, 
different conduction times along corticospinal pathways originating from 
different cortical areas account for variability in the timing of descending 
volleys. Furthermore, fast- and slow-conducting corticospinal neurons add 
additional dispersion in the arrival time of the volleys to the spinal cord. The 
corticospinal neurons respond to a single TMS with variable number of D- and 
I-waves and can thus result in different patterns of presynaptic activation (92). 
Hence, it appears that TMS activates CST in a complex fashion. Interaction of 
TMS- and PNS-induced volleys in CST cannot be predicted precisely in 
humans. Therefore, a simple approach to LTP induction based on an STDP 
model when only spike timing is considered does not permit fulfilling the 
potential of PAS. Moreover, high dispersion in the central and peripheral 
conduction time in CST of neurological patients must be considered when 
designing a PAS protocol. Importantly, LTP is more sensitive to spike-timing, 
EPSP size, and postsynaptic depolarization. In contrast, LTD is induced in a 
wider time window (-75 to 5 ms) than LTP (+5 to +25 ms) and does not require 
sufficient postsynaptic depolarization (73). Even a small shift in coincidence of 




in a conventional PAS protocol. High-frequency stimulation (>40 Hz) permits 
neglecting of spike-timing principle for LTP induction (73) and makes 
application of a PAS protocol with high-frequency PNS feasible in SCI patients. 
6.2.2 Experiment 2.2 
PAS with a suboptimal TMS target is rescued with high-
intensity TMS 
Cortical mapping in SCI patients is often challenging due to cortical 
reorganization. This study tested the efficacy of our PAS protocol when the M1 
mapping is inaccurate. 
6.2.2.1 RESULTS 
A gain in MEP potentiation became significant on the third day of PAS by 
Wilcoxon signed-rank test for both the stimulated suboptimal spot (311 ± 
141%, p = 0.043) and the adjacent sites (166 ± 26, p = 0.043). MEP amplitudes 
increased more on the third vs the first day in the stimulated suboptimal spot 
(184 ± 38%, p = 0.043) than in the adjacent area (147 ± 35%, p = 0.043), but 
the difference was not significant (Figure 9). Moreover, MEP amplitude 
increased significantly on the eighth vs the first day (measurement before PAS) 
only in the stimulated spot (209 ± 50%, p = 0.043 by Wilcoxon signed-rank 
test) (Figure 10). 
6.2.2.2 DISCUSSION 
M1 mapping is sometimes difficult in SCI individuals. M1 mapping is more 
complicated in severe than in mild SCI. The results demonstrated a gradual 
increase of MEP potentiation on the third day and the MEP baseline on fifth 
day after the 3-day PAS. TMS administered at 100% of MSO induces a wide E-
field. Its maximum is located beneath the coil centre and field strength 
attenuates gradually outwards. Thus, TMS delivered to a suboptimal spot at 
100% MSO also activates an adjacent area with lower intensity. Presumably, 
PAS induced stronger potentiation of MEPs corresponding to the stimulated 
suboptimal spot. This supports administration of PAS with TMS at 100% MSO 
in patients when precise M1 mapping is impossible. Three-day PAS also 
demonstrated a cumulative effect on MEPs, justifying long-term application of 





Figure 9 MEP potentiation is more effective in the stimulated spot. MEP potentiation of 
individual subjects measured from the stimulated spot (A) and the adjacent area (B). 
Adapted from Tolmacheva et al, 2019 (study II). The original publication is distributed 
under Creative Commons Attribution 4.0 International License. 
 
  
Figure 10 Greater increase of MEP baseline in the stimulated spot. MEP ratio from pre-PAS 
measurements during 3-day PAS and MEP measurements recorded subsequently 
up to the eighth day of the experiment, normalized to the first day. Adapted from 
Tolmacheva et al, 2019 (study II). The original publication is distributed under 




6.3 STUDY III 
6.3.1 Experiment 3.1  
Increase of PAS frequency does not further enhance PAS outcome 
A shorter stimulation session would make long-term PAS more convenient 
for SCI patients. This experiment compared the efficacy of a shorter 0.4-Hz 
PAS protocol with the originally used 0.2-Hz PAS protocol.  
6.3.1.1 RESULTS 
A 0.4-Hz PAS protocol increased MEP amplitudes immediately after the 
stimulation (204 ± 73%, p = 0.038). At 30 min after the session, a trend 
towards MEP increase (120 ± 10%, p = 0.066) was observed. MEPs returned 
to baseline at 60 min (103 ± 11%, p = 0.77). Our previously used standard 0.2-
Hz PAS displayed a trend toward MEP increase (193 ± 43%, p = 0.66) 
immediately after the stimulation. MEPs increased significantly at 30 min (177 
± 24%, p = 0.008) and at 60 min (147 ± 10%, p = 0.008) (Figure 11).    
 
Figure 11 MEP potentiation after 0.2-Hz and 0.4-Hz PAS protocols. 0.2-Hz PAS induced 
greater and more persistent increase of MEP amplitudes. Adapted from Mezes et 






Both tested PAS protocols enhanced MEPs. This effect persisted longer after 
0.2-Hz than 0.4-Hz PAS. The duration of the stimulation session and PAS 
frequency could both influence the results. In a classical PAS setup, a 30-min 
session at lower pairing frequency (0.05-0.01 Hz) potentiated MEPs up to 30 
min (54,63). Consistently, 132 PAS activations delivered at 0.2 Hz over 11 min 
increased MEP amplitudes up to 20 min after the stimulation, whereas 90 PAS 
activations delivered at 0.05 Hz for 30 min did not elicit a significant MEP 
potentiation (93). A study that specifically examined the influence of PAS 
frequency demonstrated that plasticity is enhanced by the number of PAS pairs 
and by prolongation of the interval between them. The evidence suggests that 
frequency and total number of PAS pairs have more prominent impact on PAS 
outcome than the duration of the session per se.  
This experiment revealed that our original 0.2-Hz PAS protocol used 
previously in patient studies is an optimal choice in balancing between 
therapeutic effect and duration of the stimulation. 
6.3.2 Experiment 3.2  
Increasing frequency of PNS train in PAS does not enhance PAS 
outcome. 
In study II, 100-Hz PNS was more efficient than 25- or 50-Hz PNS in a PAS 
protocol. This experiment explored whether a further increase of PNS 
frequency enhances the PAS outcome. 
6.3.2.1 RESULTS 
A PAS with 100-Hz PNS was compared with PAS protocols with 200-Hz 
PNS (PAS/200) and 400-Hz PNS (PAS/400). PAS/100 induced significant 
MEP potentiation immediately after (198 ± 25%, p = 0.005) and at 30 min 
after the stimulation (189 ± 28%, p = 0.009). The PAS/200 increased MEP 
amplitude immediately after (182 ± 22%, p = 0.022). PAS/400 did not 
potentiate MEPs. The PAS/100, PAS/200, and PAS/400 protocols differed 
significantly in between-group analyses of all time points. Post-hoc analysis 
revealed no difference between MEPs elicited by the PAS/100 and the 
PAS/200 protocols. The PAS/400 was less effective in enhancing MEPs than 





Increasing PNS frequency from 100 Hz to 200 Hz and to 400 Hz did not 
enhance the efficacy of PAS in potentiating MEPs. The possible mechanism of 
high-frequency PNS trains to advance postsynaptic depolarization does not 
seem to contribute solely to PAS outcome (see paragraph 6.2.1.2). Additional 
coincidences between multiple TMS-induced volleys and multiple pulses of 
200- and 400-Hz PNS trains did not enhance the PAS outcome. Lack of further 
growth in MEP potentiation could be explained by mechanisms of BDNF 
release triggered by elevation of intracellular calcium important in LTP 
induction. Cellular studies suggest that BDNF release depends on stimulus 
pattern and augments LTP progressively when stimulation frequency 
increases from 5 Hz to 50 Hz but with no added effect for 100 Hz (94-97). 
Absence of subsequent enhancement of LTP at frequencies greater than 100 
Hz could reflect modification of BDNF secretion. This might explain the 
smaller MEP potentiation in PAS protocols with PNS at higher frequencies. In 
addition, the limited efficacy of the PAS/200 and the PAS/400 could be 
explained by the shorter time window for volley coincidence provided by these 
protocols.  
Thus, PAS with a 100-Hz PNS train is the optimal choice out of the protocols 
tested so far. 
 
  
Figure 12 MEP potentiation after PAS with 100-Hz, 200-Hz, and 400-Hz PNS. PAS with 100-
Hz PNS displayed stronger and longer MEP potentiation. Adapted from Mezes et al, 





6.3.3 Experiment 3.3  
PAS with 20-Hz TMS inhibited corticospinal transmission 
A paired-pulse TMS could increase the probability of coincident neuronal 
events in the spinal cord and could augment PAS outcome. 
6.3.3.1 RESULTS 
PAS with a paired-pulse TMS suppressed MEPs at all time points of the 
follow up. MEP amplitudes decreased significantly by -64 ± 14% (p = 0.043) 
immediately after, by -66 ± 20% (p = 0.23) at 30 min, and by -52 ± 12%, (p = 
0.043) at 60 min (Figure 13).  
6.3.3.2 DISCUSSION 
The rationale for selection of 20-Hz paired-pulse TMS was to keep TMS 
intensity as high as possible, since TMS delivered at 100% of MSO is a 
characteristic feature of our PAS protocol (see paragraph 3.4.1 TMS in PAS). 
According to TMS safety guidelines, a 20-Hz paired-pulse can be delivered at 
96% of the MSO. This frequency enabled synchronization of two high-intensity 
TMS pulses with the pulses of a PNS train. A 20-Hz paired-pulse TMS 
 
Figure 13 MEP depression after PAS utilizing 20-Hz paired-pulse TMS. The protocol induced 
lasting reduction of MEP amplitudes. Adapted from Mezes et al, 2019 (study III). The 




has a 50-ms interval between the two TMS pulses. Paired-pulse TMS given 
at intervals of 50-200 ms suppresses MEPs through long-interval intracortical 
inhibition (LICI) (98). However, the 50-ms interval is a borderline value for 
LICI and intracortical facilitation (ICF). For instance, Valls-Sole et al (1992) 
observed an increase of MEP amplitudes at double-pulse intervals of 25-50 ms 
and MEP suppression at intervals of 60-150 ms (99). The site of LICI action 
may involve both supraspinal and spinal inhibitory mechanisms. MEP 
suppression evoked by LICI protocols with intervals of 50-200 ms may relate 
to cortical modulation (100,101). Thus, the observed MEP suppression needs 
not to indicate spinal inhibition. It is probable that the induced LTP-like 
plasticity at the corticomotoneuronal synapses by PAS with a paired-pulse 
TMS is masked by a robust cortical LICI. However, I-waves are enhanced in 
epidural recordings despite MEP suppression after paired-pulse TMS 
delivered at a 50-ms interval. This MEP inhibition may involve a subcortical 
(likely spinal) mechanism (102). Although existing literature on mechanisms 
of LICI are ambiguous, a PAS protocol with a 20-Hz paired-pulse TMS induced 
MEP suppression and is therefore not useful in treatment of SCI patients. 
6.4 STUDY IV:  
Long-term PAS restores some motor function in 
traumatic SCI 
A single PAS session can facilitate transmission in the corticospinal tract 
associated with increased motor output in healthy individuals. This proof-of-
principle study demonstrated for the first time the potential of PAS for motor 
rehabilitation when applied as a long-term intervention in two incomplete 
traumatic SCI patients.  
6.4.1 Results 
6.4.1.1 TETRAPLEGIC PATIENT 
 A tetraplegic patient received PAS to the right hand and control PNS to left 
MN for 12 weeks. The MMT score improved in the PAS-treated right hand 
already at 7 weeks after the onset of stimulation (on average by 0.5 points at 7 
weeks and by 1.13 points at 12 weeks) and remained increased at the 1-month 
follow up. In contrast, the MMT score of muscles innervated by left MN did 





Figure 14 Motor score of a tetraplegic patient. Motor scores of muscles innervated by MN, UN, 
RN, and other nerves are presented separately. The changes in the left hand were 
not observed while receiving PNS. Motor score of both hands improved during PAS 
administration and at follow up. Figure from Shulga et al, 2016 (study IV). The 
original publication is distributed under Creative Commons Attribution 4.0 
International License. 
by 0.17 points at 12 weeks). However, after subsequent administration of PAS 
for 12 weeks to the left hand, the MMT score increased by 0.88 points. A 
smaller MMT score increase was also observed in the non-stimulated hand 
muscles. MEPs of left APB stimulated by PNS alone did not increase in 
amplitude (Figure 14). Ultimately, the improvement in muscle strength 
enabled grasping with the PAS-treated hand. 
The sensory or spasticity scores did not change significantly. The sum of 
light touch and pin prick assessed in C2-T1 dermatomes for the right/left hand 
was 21/16 before and 20/14 after the intervention.  
The patient reported less neuropathic pain during the intervention and 
follow up. Before the intervention, pain in the shoulder and scapular area 
occurred about 3 times per week; after the intervention, similar pain occurred 
only in the shoulder area once in 2 weeks. 
6.4.1.2 PARAPLEGIC PATIENT 
The paraplegic patient received PAS first to the left leg. At first, slight dorsi- 
and plantarflexion of the left ankle was observed in the left foot at 5 weeks after 





Figure 15 EMG recording from the medial GC in a paraplegic patient before, during PAS, and 
at follow up. Vertical dark grey lines represent a command for plantarflexion. Before 
PAS, no EMG movement-related activity is seen. Voluntary EMG activity appears at 
week 8 of PAS and continues growing over the intervention. Restored plantarflexion 
remains at 1 month after PAS termination. Figure from Shulga et al, 2016 (study IV). 
The original publication is distributed under Creative Commons Attribution 4.0 
International License. 
right leg was not stimulated and remained paralyzed. PAS of the right leg 
started at the tenth week. Voluntary movements in the right ankle were first 
seen after 3 weeks of stimulations. Voluntary activity of both feet were detected 
in EMG after 8 weeks of PAS; movement-related EMG activity and MEP 
amplitudes of stimulated muscles increased during the intervention and at the 
1-month follow up (Figure 15). The L2-S3 dermatomes had abnormal sensory 
score before the intervention. The sum of light touch and pin prick from these 
dermatomes was 7 before the intervention, 8 at 8-week, and 9 at 20-week 
evaluations. Sensory scores did not change significantly after the intervention. 
The patient did not have spasticity before or after the intervention. 
The patient had daily throbbing bilateral pain of VAS 3-6 in L2 dermatome 
before the intervention. During the intervention and at the 1-month follow up, 





The main result of the study for the tetraplegic patient was regaining the 
ability to grasp. The non-stimulated muscles also improved. It is plausible that 
changes in motor behaviour induced by PAS-related improvement of specific 
muscles engaged non-stimulated muscles, as they form a unitary functional 
motor system (103). This is consistent with observations on increased MEP 
amplitudes of non-target muscles after cortical PAS (54,76). 
For the paraplegic patient, the main result was the appearance of subtle 
dorsi- and plantarflexion detected on EMG already at 8 weeks of PAS in 
previously paralyzed legs. The patient was not able to imagine dorsi- and 
plantarflexion before PAS treatment. During PAS, she first regained the ability 
to imagine the movements. The visible movements detected in EMG appeared 
after this.  
Sensory scores were not modified significantly by long-term PAS. However, 
the paraplegic patient regained the ability to feel the acquired movements. This 
study was the first indication that long-term PAS with settings developed in 
our laboratory restored some voluntary control over previously paralyzed hand 
and leg muscles. The first improvement was already seen at 7 weeks after 
stimulation onset and increased until the end of intervention, suggesting that 
a longer period of stimulation may result in further motor improvement.  
6.5 STUDY V 
Long-term PAS improves motor function in traumatic 
SCI patients. 
Study V compared for the first time the efficacy of long-term PAS to long-
term PNS in traumatic SCI patients. PAS was delivered to one hand of the 
patients. The contralateral hand received only PNS. This setup ameliorated 
patient-related heterogeneity in medication, type of injury, and genetic factors 
in comparison of the effects of PAS and PNS interventions. 
6.5.1 Results  
The average MMT score of the PAS-treated hand increased by 0.74 ± 0.18 
points (p < 0.0001). The average MMT score of the PNS-treated hand 
increased by 0.55 ± 0.08 points (p < 0.0001) immediately after the 
intervention. However, during the first month of follow up (change between “1 
month” and “after” evaluations), the MMT score of the PAS-treated hand 




change. At 1 month, the MMT score increase was significantly higher in the 
PAS-treated hand (1.02 ± 0.17, p < 0.0001) than in the PNS-treated hand (0.65 
± 0.14 p < 0.0001) (Figure 16). The patients reported functional benefit of the 
intervention. For instance, patient 1 was able to open bottles and patient 3 was 
able to open doors with the PAS-treated hand. 
  
Figure 16 MMT score improvement. Average MMT score increase in muscles innervated by 
stimulated nerves. Adapted from Tolmacheva et al, 2017 (study V). The original 
publication is distributed under Creative Commons license. 
Spasticity and EMG were not modified by PAS and PNS. The number of 
spasticity-related spikes in EMG recorded from APB, ADM, and BR decreased 
by 33 ± 35 spikes in the PAS-treated hand (p = 0.24) and by 23 ± 16 spikes in 
the PNS-treated hand (p = 0.4). 
The sensory score from dermatomes C2-T10 did not change after the 
intervention. The difference between the assessments before and after PAS was 
-0.8 ± 1 point (p = 0.46) for light touch and 3 ± 1.8 points (p = 0.14) for pin-
prick scores in the PAS-treated hand and 1.2 ± 0.6 (p = 0.1) for light touch and 
-1.4 ± 2 (p = 0.7) for pin-prick scores in the PNS-hand. 
PAS and PNS did not modify F-responses measured from the UN and MN 
before and immediately after the intervention. 
Three patients did not have neuropathic pain before or after the 
intervention. Patient 1 had unpleasant feelings in the right arm and feet, which  
disappeared after the intervention. Patient 5 had daily pain of VAS 3 in both 




VAS 4-5 and returned to baseline level after the follow up. This change in pain 
score is probably related to interruption of regular peripheral stimulation for 
the period of the intervention and follow up. 
6.5.2 Discussion 
Although the MMT score increased immediately after the intervention in 
both hands, only the PAS-treated hand continued to improve during the follow 
up. PNS-induced MMT improvement could be explained by training of 
stimulated muscles (104). Motor imagery leads to descending activation along 
the CST (105). Hence, PNS combined with motor imagery may provide 
conditions for associative synaptic plasticity at the spinal cord and may 
contribute to MMT score improvement. However, synchronization of motor 
imagery with PNS is difficult to control and precise timing of descending and 
ascending activities required for STDP is improbable. The latency and 
persistence of F-responses did not change after the intervention, suggesting 
that peripheral nerve changes did not contribute to observed motor 
improvement. Changes in spasticity did not explain the MMT improvement by 
PAS.  
This study provided the first direct evidence of the superiority of long-term 
PAS over long-term PNS in chronic SCI patients of traumatic origin. The 
results of this study and the pilot study suggest that longer application of PAS 
could yield greater motor improvement. 
6.6 STUDY VI 
Long-term PAS enabled functional improvement in 
non-traumatic SCI patients. 
Neurological SCI constitutes a considerable proportion of SCI. Due to 
different aetiology and a usually milder injury, the response to PAS in 
neurological SCI could differ from traumatic SCI. This study investigated the 
efficacy of long-term PAS in neurological SCI patients. In this study, PAS was 
administered to one hand and the contralateral hand did not receive any 
stimulation to detect possible motor improvement in the non-stimulated hand.  
6.6.1 Results  
After the intervention, the average MMT score of the PAS-treated hand 




points (p = 0.043) at the 1-month, and by 1.7 ± 0.5 points (p = 0.043) at the 6-
month evaluations (Figure 17). The MMT score of the non-stimulated hand 
also improved in 3 patients who had an abnormal MMT score before the 
intervention. However, the MMT score improved more in the PAS-treated 
hand than in the non-stimulated hand. The ratio of the PAS- vs the non-
stimulated hand from 3 patients was 157 ± 27% after the intervention, 129 ± 
12% at 1 month, and 130 ± 9% at 6 months. The MMT score increase was 
accompanied with improvement in functional tests and hand strength in the 
stimulated but not in the non-stimulated hand. This was reflected in more 
confident use of the stimulated hand in everyday tasks such as dressing, hair 
washing, playing guitar, and handling a steering wheel. 
Palm pinch, key pinch, and box and block tests improved at all evaluations, 
whereas tip pinch improved at 1 month evaluation, and digital dynamometry 
at 1- and 6-month evaluations. Consistent with previous patient studies, the 
spasticity score did not change in either hand. 
6.6.2 Discussion 
Motor improvement achieved by PAS in both hands persisted up to 6 months. 
The average MMT score increase was larger in patients with neurological than 
traumatic SCI. However, direct comparison of PAS efficacy is hampered by 
differences in PAS protocols and heterogenous patient groups. Patients with 
more recent SCI improved more. Outcome was followed up to 6 months and 
revealed a MMT score increase after PAS termination. This probably relates to 
more active use of the hands in everyday life due to acquired improvement 
during PAS. The MMT score of the non-stimulated hand also increased. 
Increased use of the PAS-treated hand could favour assistance of the 
contralateral hand during bilateral tasks. Moreover, interhemispheric and 
interspinal interactions are present in innervation of the hands. The cortical 
changes followed by SCI are characterised by enhanced activation in the 
primary somatosensory cortex and supplementary motor area, which may 
cause elevated interhemispheric inhibition to the less injured side (106). Thus, 
PAS-associated recovery of the stimulated hand leading to some restoration of 








Figure 17 MMT score change after PAS in the muscles innervated by the stimulated nerves. (A) 
Average MMT score increase. (B) Individual MMT. Adapted from Tolmacheva et al, 
2019 (study VI). The original publication is distributed under Creative Commons 




7 GENERAL DISCUSSION 
7.1 LIMITATIONS OF THE STUDIES 
7.1.1 PAS outcome measured with MEPs 
PAS outcome was measured with MEPs in studies I, II, and III. MEP used 
as a global measure of corticospinal excitability is somewhat limited in 
interpretation of the PAS outcome. A conventional MEP study does not define 
the level of CST contributing to MEP amplitude change. An after-PAS increase 
of MEP amplitudes can be attributed to modulation at the spinal cord and in 
the cerebral cortex.  
Modulation of cortical circuits affects MEP amplitudes. A control 
experiment with TMS delivered alone in study I revealed no significant MEP 
changes, suggesting that TMS alone does not explain the PAS effect. 
Corticospinal transmission can also be influenced by cognitive factors during 
MEP measurements, which are difficult to control. For example, thinking of a 
movement facilitates corticospinal transmission plausibly by diminishing 
intracortical inhibition (83,107). Focused thinking on topics different from 
movement may reduce the TMS-elicited MEP amplitudes (108). The pattern of 
motor-neuron discharges in the spinal cord in response to TMS-induced pulses 
also influence MEP size. The number of recruited lower motor neurons, the 
number of motor neurons with repetitive discharge to the TMS stimulus, and 
synchronization of discharge of different motor neurons to the given TMS 
stimulus can modify MEP size (108). The number of recruited motor neurons 
is sensitive to background muscle contraction. Concurrent voluntary 
contraction is a powerful tool to enhance corticospinal excitability; even 
contraction of 5-15% of the maximum force level results in maximum MEP 
amplitudes. Analysis of continuous EMG during MEP measurements in our 
studies excluded this factor. For MEP elicited by high-intensity TMS, repetitive 
discharge of motor neurons is a relevant factor, as TMS evokes multiple 
descending volleys that causes motor neurons to fire more than once. A large 
between-subject variability in multiple activation of pyramidal cells to a given 
TMS stimulus does not enable precise estimation of the rate of descending 
volleys in each individual (108). Hence, this factor cannot be standardised 
during MEP measurements. Because motor neurons independently fire in 




phase cancellation of desynchronized motor neurons; a negative phase of some 
motor-unit potentials is neutralized by a positive phase of the others (109). 
Applying TMS to CST at the cervicomedullary junction enables assessment 
of corticospinal integrity at the spinal level (110-112). In contrast to MEP evoked 
by TMS, cervicomedullary stimulation does not activate corticospinal 
pathways selectively, as cervical TMS at MT intensity activates a large volume 
of the spinal cord involving multiple corticospinal pathways.  
F- and H-response studies could be used for assessment of changes at the 
spinal cord. An F-response study could examine the excitability of a 
motoneuronal pool via antidromic activation. H-response is considered as an 
electrophysiological equivalent of the monosynaptic tendon reflex and reflects 
segmental motor excitability. Thus, F- and H-responses are not representative 
of the corticomotoneuronal synapses that are the targets in our PAS. 
Consistently, no change of F-responses was observed after spinal PAS (63). 
MEPs were not a reliable method for outcome evaluation in patients due to 
spike-contaminated EMG, which confounds interpretation of MEP amplitude 
changes. A conventional MEP study would not provide exclusive information 
on efficacy of the corticomotoneuronal synapses. However, MEPs are broadly 
utilized for assessment of corticospinal excitability. It is a sensitive, objective, 
and feasible test. Focal TMS stimulation of M1 enables assessment of 
excitability of specific corticospinal pathways that are targets in PAS. 
Additional paired-pulse TMS studies could be used for estimation of cortical 
excitability to resolve a contribution of cortical modulation after spinal PAS. 
7.1.2 Patient recruitment 
SCI patients who have contraindications to TMS cannot undergo PAS. 
Patients below 18 years or over 75 years were not considered for PAS. We did 
not recruit patients who had SCI over 15 years ago or patients with congenital 
SCI, as these patients are not expected to be sufficiently responsive to PAS. 
Drug and alcohol abuse, psychiatric disease, and tumours of any location were 
excluding factors. During long-term PAS, the skin under the stimulating 
electrodes for PNS should be monitored for damage, as SCI individuals have 
susceptibility to skin problems. However, skin damage was not observed in any 
studies of this dissertation. Comorbid diseases that may interfere with 
interpretation of results, such as neuropathy, severe spasticity, or severe 
arthrosis may also be exclusion criteria. Progressive SCI were not considered 
for PAS, as the naturally progressive course of disease would mask PAS effect. 
Patients treated with tendon-muscle and nerve-transfer hand surgery should 




enable reliable identification of the parameters related to the CST activation. 
Long-term intervention that requires regular visits may exclude patients who 
live far from the laboratory. 
Although recruitment of patients with the same SCI classified by AIS is 
feasible, these patients would form a heterogeneous group by localization and 
extent of lesion. It is thus difficult to perform a study with an appropriate 
control for these characteristics. However, patients with chronic SCI serve as 
their own control, as no spontaneous recovery is observed at the chronic stage. 
7.2 POTENTIAL PAS MECHANISMS 
7.2.1 Action at the spinal cord  
Our PAS protocol was designed to strengthen the corticomotoneuronal 
synapses of spared corticospinal connections in SCI individuals. Based on 
individual adjustment of PNS and TMS timing, PAS presumably exerted an 
action on the corticomotoneuronal synapses at the spinal cord. Our PAS 
protocol employed a pre-postsynaptic activation model of synaptic plasticity. 
Studies on spinal PAS evaluating PAS outcome with cervicomedullary 
stimulation and transcranial electrical stimulation also suggest involvement of 
the spinal cord in the observed MEP potentiation (63,64).  
PNS adjusted for activation of motor fibres also activates the sensory tract. 
Activation of the sensory tract during PAS possibly implements additional 
relevant neuronal interaction in the spinal cord via the tendon reflex loop (H-
reflex) (68). The H-reflex is evoked by activation of the Ia afferents that have 
an excitatory monosynaptic input to the homonymous motoneuron. Since 
latency of H-response nearly matches to the F-response latency, a calculated 
ISI in a PAS protocol would synchronize inputs from a motoneuronal axon, a 
corticospinal neuron, and Ia afferent to homonymous motoneuron (113). It is 
therefore conceivable that the intended pre-postsynaptic activation 
mechanism in our PAS is strengthened with an additional sensory input (18). 
This secondary mechanism may serve the goal of the study to augment 
corticospinal transmission. 
7.2.2 Action at the cortical level 
A sensory impulse ascends to the sensory cortex and synapses 
intracortically to M1. As such, our PAS protocol could actualize cortical PAS 




convergent model of synaptic plasticity (18,54). In our PAS protocol, the 
nearest interaction of PNS- and TMS-induced inputs to a pyramidal cell is 
provided by the first pulse of the PNS train and the latest I-wave. The delay of 
the converged inputs would be approximately 5 ms for a hand and 15 ms for a 
foot muscle, with TMS-induced inputs preceding the PNS-induced volleys. 
Subsequent pulses of PNS train and earlier I-waves preserve the same TMS-
prior-PNS order but with a greater delay. This order of activation would lead 
to suppression of motor output (see 3.4.3 Interstimulus interval). High-
intensity TMS could also activate the axonal hillock of the pyramidal cell. This 
could actualize a pre-postsynaptic PAS model via backpropagation of an action 
potential to postsynaptic dendrites of the pyramidal cell (18). Still, this type of 
neuronal interaction would probably induce LTD, since postsynaptic 
activation precedes presynaptic activation. Thus, at first approximation, one 
could argue for a supplementary action of our PAS protocol, resulting in 
suppression of M1 output. However, our PAS protocol enhanced MEPs in all 
experiments. This suggests that either our PAS protocol induced a modest 
cortical effect that was overridden with a targeted potentiation in the 
corticomotoneuronal synapses or that other neuronal interactions occur at the 
cerebral cortex. This is also supported with results where long-term PAS 
restored movement-induced modulation of sensorimotor spontaneous activity 
that was accompanied with neurological improvement in SCI patients 
(Vanhanen et al, submitted). However, it is questionable whether the restored 
sensorimotor activity modulation was due to a direct effect of PAS on the 
cerebral cortex or developed secondarily as a response of the sensorimotor 
system to PAS-induced changes in the spinal cord.  
Considering PNS and TMS timing in our PAS protocol, it is likely that our 
PAS protocol does not have a sole operant mechanism. Previous experiments 
on long-term synaptic plasticity have been conducted in cell models. These 
studies revealed timing rules for LTP and LTD induction and were used as a 
simplified model that enables prediction of PAS effects in humans. 
Determination of all possible pathways and neuronal interaction over non-
invasive stimulation is rather challenging in humans. Accumulated knowledge 
on PAS in human studies has revealed facilitation of corticospinal output at a 
range of ISI (56,58). Potentiation of M1 projections to intrinsic hand muscles 
requires predominantly the order when a sensory input to the pyramidal cell 
precedes activation by TMS. For leg muscles, MEP potentiation can also be 
seen in a reverse order (58). These conclusions were drawn from studies that 
employed a classical PAS protocol; in contrast, our modified PAS protocol 





However, there is a high interindividual variability in responsiveness to 
conventional facilitatory PAS protocols, characterized by no effect or even 
suppression of the M1 output. Stable traits-like factors influencing PAS effect, 
such as age, neuroanatomical differences, and genetic factors have been 
determined. In addition, temporal state-related factors, such as preceding 
physical activity, medication, circadian fluctuation, and focused attention can 
change the PAS outcome (56). 
7.3 BENEFITS OF A LONG-TERM PAS ADMINISTRATION 
In healthy-subject studies, the efficacy of a single PAS session was 
demonstrated with MEP potentiation that was shown to correlate with 
improvement in motor function (63,64). It is therefore presumed that the 
transient neurophysiological effect of a single-session PAS is predictive of 
long-term behavioural effects. Study IV showed a progressive improvement of 
relevant measures during 21-24 weeks of PAS treatment. A first-ever 
progressive full restoration of hand muscle strength was described after 47 
weeks of modified PAS in a chronic SCI patient (AIS B); the MMT increase was 
associated with considerable functional improvement in the SCIM score (115). 
Thus, duration of PAS influences the extent of achieved motor improvement. 
This could be attributed to the cumulative effect of PAS seen in experiment 2.2 
and to an increased use of the hand once function has been regained during 
long-term treatment. Similarly, the patient’s motor performance may improve 
beyond PAS treatment, as was observed in study VI. MMT increased more in 
patients with less severe non-traumatic SCI (AIS D) than in traumatic SCI 
patients (AIS B and C). However, two traumatic SCI patients with a 
comparable gain in MMT exhibited some functional improvement as well. This 
highlights that patients with less affected motor function could benefit 
functionally during 4-6 weeks of PAS. Most improvement was already seen 
during the first 2 weeks of long-term PAS. It is probable that for patients with 
low muscle strength at baseline, longer stimulation is required to achieve 
functional improvement (115). 
Spontaneous recovery in the chronic stage of SCI is unlikely (114). Plastic 
changes in CST in response to neuromodulation interventions are not so 
prominent as during the first year since injury. However, all 12 chronic patients 
with heterogenic origin and severity of SCI, time since injury, and age 
responded to long-term PAS treatment. It is plausible that the observed motor 
improvement was due to PAS. All patients tolerated long-term PAS well and 





7.4 PAIRED VERSUS UNPAIRED STIMULATION 
The improbable contribution of 0.2-Hz TMS to change corticospinal 
excitability is discussed in study I (paragraph 6.1.2). 
FES is effective in rehabilitation of motor function. A special FES setup 
could actualize the principles of associative synaptic plasticity at the spinal 
cord by inducing antidromic activation of motoneurons (21). However, this 
remains speculative, since principles of Hebbian rules require precise neuronal 
activations in the range of a few milliseconds. It seems implausible that 
voluntary contraction during FES could be adjusted by an individual with such 
accuracy. Moreover, PAS has an advantage over FES, as PAS can restore 
voluntary control over previously paralyzed muscles. Even a small motor 
improvement in muscle strength that enables regained function would be 
critical for the overall rehabilitation outcome. 
In addition to the action of PNS itself, PAS bears an emergent property, 
induction of synaptic plasticity, which results from conditioned neuronal 
interactions. This unique feature of PAS may advance this technique over 
single-mode stimulation. Indeed, study IV and V demonstrated the superiority 
of long-term PAS over long-term PNS. In study IV, long-term PNS did not 
increase MMT score when applied to MN, although subsequent administration 
of PAS to three hand nerves of the same hand increased MMT score. The effect 
of PNS administered to only one nerve may not be sufficient to induce motor 
improvement in our patient with severe SCI. 
 In study VI, motor improvement was also observed in the non-stimulated 
hand. The contribution of PNS to the observed motor improvement in study V 
cannot be separated from the bilateral effect of PAS. To investigate therapeutic 
potential of PNS with parameters paralleling our PAS protocol, long-term PNS 
was delivered to one hand in chronic SCI patients with similar clinical patient 
characteristics as in study VI. The MMT score increased after long-term PNS 
and was sustained at a 1-month follow up. However, the level of a MMT score 
increase was substantially lower in the PNS-treated hand (average 0.59 points) 
than in the PAS-treated hand in study VI (average 1.44 points) and was not 
associated with functional improvement (116). Nonetheless, long-term PNS 
with the parameters used demonstrated effectiveness in motor improvement 
(although less than long-term PAS) and can be offered as rehabilitation for an 
SCI patient with contradictions to TMS or when TMS is not available. 
In this dissertation, 0.2-Hz PAS/100 was developed empirically in series of 




experiments of this dissertation employing 0.2-Hz PAS/100 induced MEP 
potentiation immediately after the stimulation in all healthy subjects (total 13 
subjects and 20 sessions), whereas the other tested PAS variants did not. This 
suggests that this variant of PAS protocol enables reliable facilitation of 
corticospinal transmission and works well in SCI individuals. 
  
7.5 FUTURE DIRECTIONS OF PAS   
The motor system is functionally and anatomically reorganized after SCI. 
Although the epicentre of injury is in the spinal cord, excitability of cortical 
circuits after SCI is also altered (78,117). Corticospinal output is reduced by 
impairments of both cortical and spinal circuits. Accordingly, enhancement of 
cortical output may elevate efficacy of spinal PAS. As such, facilitatory rTMS 
could be employed in the spinal PAS protocol. Moreover, long-term rTMS itself 
may induce favourable plasticity at the cerebral cortex and contribute to 
restoration of corticospinal transmission. 
Individuals in the acute or subacute stage of SCI could respond to PAS 
treatment better, as spontaneous recovery can be promoted with PAS. Patients 
with more recent SCI benefited more in studies V and VI. Moreover, early start 
of rehabilitation may prevent muscle atrophy and spasticity, which worsen the 
overall condition of people with SCI. 
PAS could be combined with other rehabilitation approaches. For instance, 
PAS can be enhanced during vagus nerve stimulation (VNS). Intensive training 
concurrently with precise VNS results in a considerably higher level of motor 
recovery in chronic neurological patients (117-120). Because PAS is capable of 
targeting plasticity in specific circuits, PAS could be combined with cell 
therapy to prevent unwanted sprouting and to guide plasticity (121). 
The parameters of a PAS protocol (duration of stimulation, frequency of 
PAS, PNS and TMS parameters) and a schedule of the treatment can be 




8 SUMMARY AND CONCLUSIONS 
The goals of this dissertation were to investigate the therapeutic efficacy of 
long-term PAS and to optimize the PAS protocol. These goals were achieved in 
the six studies.  
 
1. Parameters of the PAS protocol influence PAS efficacy. A 
comprehensive approach in the assessment of parameters of our modified PAS 
protocol enabled detection of the optimal settings. A variant of PAS 0.2 Hz 
employing a single TMS at 100% MSO and 100-Hz PNS train is the most 
effective PAS protocol tested so far. 
2. Long-term PAS had a therapeutic effect and demonstrated safety and 
feasibility in chronic SCI patients of different ages, SCI severity and 
pathogenesis, and time since injury. 
3. Long-term PAS was more efficient than long-term PNS. 
4. Long-term PAS is capable of restoring hand functions. Longer PAS 
administration generates a better functional improvement. 
 
PAS treatment has demonstrated superiority over ES, which is broadly used 
as conventional rehabilitation in SCI. PAS presumably strengthens residual 
connections of CST in the spinal cord that serve as a substrate for motor 
recovery after injury. Modification of our PAS protocol enabled resolving 
issues relevant for SCI patients that were encountered in the classical PAS 
protocol. Our long-term PAS was effective in all patients. This promising result 
justifies further investigation of long-term PAS in larger cohorts of patients to 
assess the full potential of this method. Many laboratories are equipped with 
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